Medical device

Information

  • Patent Grant
  • 9707027
  • Patent Number
    9,707,027
  • Date Filed
    Friday, May 20, 2011
    13 years ago
  • Date Issued
    Tuesday, July 18, 2017
    7 years ago
Abstract
A medical device is described having a handle and an end effector coupled to the handle. The end effector has at least one electrode for providing electrical signals to a tissue or vessel to be treated. An RF drive circuit is provided for generating an RF drive signal that is applied to the end effector electrode. The RF drive circuit includes a resonant circuit and a frequency controller is used to vary the frequency of a signal passed through the resonant circuit in order to control the power supplied to the end effector electrode.
Description

This application is a U.S. national stage application of and claims the priority benefit of PCT/GB2011/000778 filed on May 20, 2011.


BACKGROUND

The present invention relates to the field of medical devices and in particular, although not exclusively, to medical cauterization and cutting devices. The invention also relates to drive circuits and methods for driving such medical devices.


Many surgical procedures require cutting or ligating blood vessels or other internal tissue. Many surgical procedures are performed using minimally invasive techniques, a hand-held cauterization device is used by the surgeon to perform the cutting or ligating. The existing hand-held cauterization devices require a desk top power supply and control electronics that are connected to the device through an electrical supply line. FIG. 10 illustrates such an existing hand-held cauterization device currently in use.


It has been known for a number of years that these existing devices are cumbersome and difficult to use during a surgical operation due to the large size of the supply and control electronics and due to the tethering of the hand-held cauterization device to the supply and control electronics. It has also been known for a number of years that these problems would be overcome by providing a battery powered hand-held cauterization device in which the power and control electronics are mounted within the device itself, such as within the handle of the device. However, it is not a simple matter of miniaturising the electronics. The power that has to be supplied to the device during the surgical procedure and the current design of the electronics is such that large capacitors, inductors and transformers as well as heat sinks and fans are required. FIG. 11 illustrates in more detail the different parts of the supply and control electronics that are used in the existing design as illustrated in FIG. 10. Whilst it is possible to reduce the size of the sensing and control electronics, other parts of the circuitry cannot be miniaturised in this way.


In particular, the existing electronics design uses circuitry for providing an adjustable 24 Volt power supply; FETs and associated drive circuitry; a transformer for increasing the supply voltage; and filtering circuitry to remove harmonics from the square wave voltage levels that are generated by the FEE switches and the transformer. Given the voltage levels and the power levels used to drive the cauterization device, the transformers and output filters all have to be relatively bulky devices and large heat sinks and a fan are required to cool the FET switches.


The present invention aims to provide an alternative circuit design that will allow the miniaturisation of the circuitry so that it can be built into the hand-held cauterization device, whilst still being able to provide the power and control required for the medical procedure.


SUMMARY

The present invention provides a medical device comprising an end effector having at least one electrical contact a radio frequency, RF, generation circuit for generating an RF drive signal and to provide the RF drive signal to the at least one electrical contact and wherein the RF generation circuit comprises a resonant circuit. In one embodiment, the radio frequency generation circuit comprises switching circuitry that generates a cyclically varying signal, such as a square wave signal, from a DC supply and the resonant circuit is configured to receive the cyclically varying signal from the switching circuitry. The DC supply is preferably provided by one or more batteries that can be mounted in a housing (such as a handle) of the device.


According to another aspect, the invention provides a medical device comprising: a handle for gripping by a user; an end effector coupled to the handle, the end effector having at least one electrical contact; battery terminals for connecting to one or more batteries; a radio frequency, RF, generation circuit coupled to said battery terminals and operable to generate an RF drive signal and to provide the RF drive signal to the at least one electrical contact of said end effector; wherein the frequency generation circuit comprises: switching circuitry for generating a cyclically varying signal (which may be a square wave pulse width modulated signal) from a potential difference across said battery terminals; and a resonant drive circuit coupled to said switching circuitry and operable to filter the cyclically varying signal generated by the switching circuitry; and wherein the RF drive signal is obtained using an output signal from said resonant circuit.


The medical device may also comprise a control circuit (which may comprise hardware and/or software) that varies the frequency of the RF drive signal. The control circuit may vary the frequency based on a measurement of the RF drive signal in order to control at least one of the power, voltage and/or current delivered to the at least one electrical contact of the end effector. In a preferred embodiment, the measurement is obtained from a sampling circuit that operates synchronously with respect to the frequency of the RF drive signal. The frequency at which the sampling circuit samples the sensed signal may be an integer fraction of the frequency of the RF drive signal.


In one embodiment, the control circuit varies the frequency of the RF drive signal around (preferably just above or just below) the resonant frequency of the resonant circuit. The resonant characteristic of the resonant circuit may vary with a load connected to the at least one electrical contact and the control circuit may be arranged to vary the RF drive frequency to track changes in the resonant characteristic of the resonant circuit.


According to another aspect, the invention provides a medical device comprising: a handle for gripping by a user; an end effector coupled to the handle and having at least one electrical contact; a radio frequency, RF, generation circuit operable to generate an RF drive signal and to provide the RF drive signal to the at least one electrical contact; and a control circuit operable to vary the frequency of the RF drive signal to control at least one of the power, the voltage and the current provided to the at least one contact of the end effector.


The RF generation circuit may comprise a signal generator that generates a cyclically varying signal at the RF frequency; and a frequency dependent attenuator that attenuates the cyclically varying signal in dependence upon the frequency of the cyclically varying signal. The frequency dependent attenuator may be a lossless attenuator and may comprise a resonant circuit having a resonant frequency at or near the RF frequency of the cyclically varying signal.


The present invention also provides a medical device comprising: a handle for gripping by a user; an end effector coupled to the handle and having at least one electrical contact; a radio frequency, RF, generation circuit operable to generate an RF drive signal and to provide the RF drive signal to the at least one electrical contact; an input for receiving a sensed signal that varies with the RF drive signal applied to the at least one electrical contact; a sampling circuit for sampling the sensed signal received at said input; a measurement circuit operable to make measurements of the RF drive signal using samples obtained from the sampling circuit; and a control circuit operable to control the RF generation circuit in dependence upon the measurements made by the measurement circuit, to vary the frequency of the generated RF drive signal; wherein the sampling circuit is operable to sample the sensed signal at a sampling frequency that varies in synchronism with the frequency of the RE drive signal.


The invention also provides a method of operating a medical device comprising generating an RF signal and applying the RF signal to at least one electrode of an end effector of the medical device and controlling the frequency of the generated RF signal to control at least one of the power, current, and voltage applied to the at least one electrode.


According to another aspect, the invention provides a method of cauterising a vessel or tissue, the method comprising: gripping the vessel or tissue with an end effector of a medical device; applying an RF signal to at least one electrode of the end effector that is in contact with the vessel or tissue; and controlling the frequency of the RF signal to control at least one of the power, current, and voltage applied to the tissue to perform the cauterisation.


The above methods may use the above described medical device, although that is not essential.


The controlling step may vary the frequency of the RF signal to control the power applied to the tissue or vessel, and the method may further comprise obtaining measurements of the impedance of the tissue or vessel and varying the desired power applied to the tissue or vessel in dependence upon the obtained impedance measurements.





FIGURES

These and various other features and aspects of the invention will become apparent from the following detailed description of embodiments which are described with reference to the accompanying Figures in which:



FIG. 1 illustrates a hand-held cauterization device that has batteries and drive and control circuitry mounted into a handle portion of the device;



FIG. 2 is a part block part schematic diagram illustrating the main components of the RF drive circuitry and control circuitry used in one embodiment of the invention;



FIG. 3 is a block diagram illustrating the main components of a controller used to control the operation of the RF drive circuitry illustrated in FIG. 2;



FIG. 4 is a timing diagram illustrating the RF drive signals applied to the cauterization device and illustrating a way in which synchronous samples may be obtained to measure the drive signals;



FIG. 5a is a plot illustrating limits that are placed on voltage and current supplied to the cauterization device illustrated in FIG. 1;



FIG. 5b illustrates a resulting power plot obtained by combining the current and voltage plots illustrated in FIG. 5a;



FIG. 6 is a plot illustrating the way in which the resonant characteristics of the RF drive circuit illustrated in FIG. 2 varies with different loads;



FIG. 7 is a flow chart illustrating the operation of a frequency control algorithm used to control the frequency of the RF drive signals applied to the cauterization device;



FIG. 8 is a plot illustrating one way in which the power limit can be varied by the control electronics during a surgical procedure;



FIG. 9 is a part block part schematic diagram illustrating the main components of another RF drive circuit and control circuit embodying the invention;



FIG. 10 illustrates the form of a prior art hand-held cauterization device which is connected to power supply and control electronics via a power supply line; and



FIG. 11 is a plan view illustrating the different components of the existing electronics used to drive and control the hand-held cauterization device illustrated in FIG. 10.





DETAILED DESCRIPTION

Medical Device


Many surgical procedures require cutting or ligating blood vessels or other vascular tissue. With minimally invasive surgery, surgeons perform surgical operations through a small incision in the patient's body. As a result of the limited space, surgeons often have difficulty controlling bleeding by clamping and/or tying-off transected blood vessels. By utilizing electrosurgical forceps, a surgeon can cauterize, coagulate/desiccate, and/or simply reduce or slow bleeding by controlling the electrosurgical energy applied through jaw members of the electrosurgical forceps.



FIG. 1 illustrates the form of an electrosurgical medical device 1 that is designed for minimally invasive medical procedures, according to one embodiment of the present invention. As shown, the device 1 is a self contained device, having an elongate shaft 3 that has a handle 5 connected to the proximal end of the shaft 3 and an end effector 7 connected to the distal end of the shaft 3. In this embodiment, the end effector 7 comprises medical forceps 9 and a cutting blade (not shown) that are controlled by the user manipulating control levers 11 and 13 of the handle 5.


During a surgical procedure, the shaft 3 is inserted through a trocar to gain access to the patient's interior and the operating site. The surgeon will manipulate the forceps 9 using the handle 5 and the control levers 11 and 13 until the forceps 9 are located around the vessel to be cauterised. Electrical energy at an RF frequency (it has been found that frequencies above about 50 kHz do not affect the human nervous system) is then applied, in a controlled manner, to the forceps 9 to perform the desired cauterisation. As shown in FIG. 1, in this embodiment, the handle 5 houses batteries 15 and control electronics 17 for generating and controlling the electrical energy required to perform the cauterisation. In this way, the device 1 is self contained in the sense that it does not need a separate control box and supply wire to provide the electrical energy to the forceps 9.


RF Drive Circuitry



FIG. 2 is a part schematic part block diagram illustrating the RF drive and control circuitry 20 used in this embodiment to generate and control the RF electrical energy supplied to the forceps 9. As will be explained in more detail below, in this embodiment, the drive circuitry 20 is a resonant based circuit and the control circuitry operates to control the operating frequency of the drive signal so that it is varied around the resonant frequency of the drive circuit, which in turn controls the amount of power supplied to the forceps 9. The way that this is achieved will become apparent from the following description.


As shown in FIG. 2, the drive circuitry 20 comprises the above described batteries 15 that are arranged to supply, in this example, OV and 24V rails. An input capacitor (Cin) 21 is connected between the OV and the 24V rails for providing a low source impedance. A pair of FET switches 23-1 and 23-2 (both of which are N-channel in this embodiment to reduce power losses) is connected in series between the OV rail and the 24V rail. FET gate drive circuitry 25 is provided that generates two drive signals—one for driving each of the two FETs 23. The FET gate drive circuitry 25 generates drive signals that causes the upper FET (23-1) to be on when the lower FET (23-2) is off and vice versa. This causes the node 27 to be alternately connected to the 24V rail (when FET 23-1 is switched on) and the OV rail (when the FET 23-2 is switched on). FIG. 2 also shows the internal parasitic diodes 28-1 and 28-2 of the corresponding FETs 23, which conduct during any periods that the FETs 23 are open.


As shown in FIG. 2, the node 27 is connected to a capacitor-inductor-inductor resonant circuit 28 formed by capacitor Cs29, inductor Ls31 and inductor Lm33. The FET gate driving circuitry 25 is arranged to generate drive signals at a drive frequency (fd) that opens and closes the FET switches 23 at around the resonant frequency of the resonant circuit 28. As a result of the resonant characteristic of the resonant circuit 28, the square wave voltage at node 27 will cause a substantially sinusoidal current at the drive frequency (fd) to flow within the resonant circuit 28. As illustrated in FIG. 2, the inductor Lm33 is the primary of a transformer 35, the secondary of which is formed by inductor Lsec37. The transformer 35 up-converts the drive voltage (Vd) across inductor Lm 33 to the load voltage (VL) that is applied to the load (represented by the load resistance Rload39 in FIG. 2) corresponding to the impedance of the forceps' jaws and any tissue or vessel gripped by the forceps 9. As shown in FIG. 2, a pair of DC blocking capacitors Cb. 40-1 and 40-2 is provided to prevent any DC signal being applied to the load 39.


In this embodiment, the amount of electrical power supplied to the forceps 9 is controlled by varying the frequency of the switching signals used to switch the FETs 23. This works because the resonant circuit 28 acts as a frequency dependent (lossless) attenuator. The closer the drive signal is to the resonant frequency of the resonant circuit 28, the less the drive signal is attenuated. Similarly, as the frequency of the drive signal is moved away from the resonant frequency of the circuit 28, the more the drive signal is attenuated and so the power supplied to the load reduces. In this embodiment, the frequency of the switching signals generated by the FET gate drive circuitry 25 is controlled by a controller 41 based on a desired power to be delivered to the load 39 and measurements of the load voltage (VL) and of the load current (iL) obtained by conventional voltage sensing circuitry 43 and current sensing circuitry 45. The way that the controller 41 operates will be described in more detail below.


Controller



FIG. 3 is a block diagram illustrating the main components of the controller 41. In this embodiment, the controller 41 is a micro-processor based controller and so most of the components illustrated in FIG. 3 are software based components. However, a hardware based controller 41 may be used instead. As shown, the controller 41 includes synchronous I,Q sampling circuitry 51 that receives the sensed voltage and current signals from the sensing circuitry 43 and 45 and obtains corresponding samples which are passed to a power, Vrms and Irms calculation module 53. The calculation module 53 uses the received samples to calculate the RMS voltage and RMS current applied to the load 39 (forceps 9 and tissue/vessel gripped thereby) and from them the power that Is presently being supplied to the load 39. The determined values are then passed to a frequency control module 55 and a medical device control module 57. The medical device control module 57 uses the values to determine the present impedance of the load 39 and based on this determined impedance and a pre-defined algorithm, determines what set point power (Pset) should be applied to the frequency control module 55. The medical device control module 57 is in turn controlled by signals received from a user input module 59 that receives inputs from the user (for example pressing buttons or activating the control levers 11 or 13 on the handle 5) and also controls output devices (lights, a display, speaker or the like) on the handle 5 via a user output module 61.


The frequency control module 55 uses the values obtained from the calculation module 53 and the power set point (Pset) obtained from the medical device control module 57 and predefined system limits (to be explained below), to determine whether or not to increase or decrease the applied frequency. The result of this decision is then passed to a square wave generation module 63 which, in this embodiment, increments or decrements the frequency of a square wave signal that it generates by 1 kHz, depending on the received decision. As those skilled in the art will appreciate, in an alternative embodiment, the frequency control module 55 may determine not only whether to increase or decrease the frequency, but also the amount of frequency change required. In this case, the square wave generation module 63 would generate the corresponding square wave signal with the desired frequency shift. In this embodiment, the square wave signal generated by the square wave generation module 63 is output to the FET gate drive circuitry 25, which amplifies the signal and then applies it to the FET 23-1. The FET gate drive circuitry 25 also inverts the signal applied to the FET 23-1 and applies the inverted signal to the FET 23-2.


Drive Signals and Signal Measurements



FIG. 4 is a signal plot illustrating the switching signals applied to the FETs 23; a sinusoidal signal representing the measured current or voltage applied to the load 39; and the timings when the synchronous sampling circuitry 51 samples the sensed load voltage and load current. In particular, FIG. 4 shows the switching signal (labelled PWM1H) applied to upper FET 23-1 and the switching signal (labelled PWM1L) applied to lower FET 23-2. Although not illustrated for simplicity, there is a dead time between PWM1H and PWM1L to ensure that that both FETs 23 are not on at the same time. FIG. 4 also shows the measured load voltage/current (labelled OUTPUT). Both the load voltage and the load current will be a sinusoidal waveform, although they may be out of phase, depending on the impedance of the load 39. As shown, the load current and load voltage are at the same drive frequency (fd) as the switching signals (PWM1H and PWM1L) used to switch the FETs 23. Normally, when sampling a sinusoidal signal, it is necessary to sample the signal at a rate corresponding to at least twice the frequency of the signal being sampled—i.e. two samples per period. However, as the controller 41 knows the frequency of the switching signals, the synchronous sampling circuit 51 can sample the measured voltage/current signal at a lower rate. In this embodiment, the synchronous sampling circuit 51 samples the measured signal once per period, but at different phases in adjacent periods. In FIG. 4, this is illustrated by the “I” sample and the “0” sample. The timing that the synchronous sampling circuit 51 makes these samples is controlled, in this embodiment, by the two control signals PWM2 and PWM3, which have a fixed phase relative to the switching signals (PWM1H and PWM1L) and are out of phase with each other (preferably by quarter of the period as this makes the subsequent calculations easier). As shown, the synchronous sampling circuit 51 obtains an “I” sample on every other rising edge of the PWM2 signal and the synchronous sampling circuit 51 obtains a “Q” sample on every other rising edge of the PWM3 signal. The synchronous sampling circuit 51 generates the PWM2 and PWM3 control signals from the square wave signal output by the square wave generator 63 (which is at the same frequency as the switching signals PWM1H and PWM1L). Thus when the frequency of the switching signals is changed, the frequency of the sampling control signals PWM2 and PWM3 also changes (whilst their relative phases stay the same). In this way, the sampling circuitry 51 continuously changes the timing at which it samples the sensed voltage and current signals as the frequency of the drive signal is changed so that the samples are always taken at the same time points within the period of the drive signal. Therefore, the sampling circuit 51 is performing a “synchronous” sampling operation Instead of a more conventional sampling operation that just samples the input signal at a fixed sampling rate defined by a fixed sampling clock.


The samples obtained by the synchronous sampling circuitry 51 are then passed to the power, Vrms and Irms calculation module 53 which can determine the magnitude and phase of the measured signal from just one “I” sample and one “Q” sample of the load current and load voltage. However, in this embodiment, to achieve some averaging, the calculation module 53 averages consecutive “I” samples to provide an average “I” value and consecutive “0” samples to provide an average “Q” value; and then uses the average I and Q values to determine the magnitude and phase of the measured signal (in a conventional manner). As those skilled in the art will appreciate, with a drive frequency of about 400 kHz and sampling once per period means that the synchronous sampling circuit 51 will have a sampling rate of 400 kHz and the calculation module 53 will produce a voltage measure and a current measure every 0.01 ms. The operation of the synchronous sampling circuit 51 offers an improvement over existing products, where measurements can not be made at the same rate and where only magnitude information is available (the phase information being lost).


Limits


As with any system, there are certain limits that can be placed on the power, current and voltage that can be delivered to the forceps 9. The limits used in this embodiment and how they are controlled will now be described.


In this embodiment, the RF drive circuitry 20 is designed to deliver a power limited sine wave into tissue with the following requirements:

  • 1) Supplied with a nominally 24V DC supply
  • 2) Substantially sinusoidal output waveform at approximately 400 kHz
  • 3) Power limited output of 45 W
  • 4) Current limited to 1.4 Arms and voltage limited to 85Vrms


The last two requirements are represented graphically in FIGS. 5a and 5b. In particular, FIG. 5a illustrates idealised plots of voltage and current for loads between 1 Ohm and 10 k Ohms on a logarithmic scale; and FIG. 5b illustrates the power delivered to the load 39 for loads between 1 Ohm and 10 k Ohms.


The frequency control module 55 maintains data defining these limits and uses them to control the decision about whether to increase or decrease the excitation frequency.


Resonant Characteristic and Frequency Control


As mentioned above, the amount of electrical power supplied to the forceps 9 is controlled by varying the frequency of the switching signals used to switch the FETs 23. This is achieved by utilising the fact that the impedance of the resonant circuit 28 changes rapidly with frequency. Therefore by changing the frequency of the switching signals, the magnitude of the current through the resonant circuit 28, and hence through the load 39, can be varied as required to regulate the output power.


As those skilled in the art will appreciate, the resonant circuit 28 is coupled to a load 39 whose impedance will vary during the surgical procedure. Indeed the medical device control module 57 uses this variation to determine whether the tissue or vessel has been cauterised, coagulated/desiccated. The varying impedance of the load 39 changes the frequency characteristic of the RF drive circuit 20 and hence the current that flows through the resonant circuit 28. This is illustrated in FIG. 6, which is a plot 65 illustrating the way in which the current through the resonant circuit 28 varies with the drive frequency for a fixed value of load impedance. As the impedance of the load 39 increases, the resonant characteristic 65 will change shape (the peak may grow or reduce in height) and will move to the left and as the impedance of the load decreases it will change its shape and move to the right. Therefore, the frequency control module 55 must operate quickly enough to track the changes in the resonant characteristic 65. This is easily achievable in this embodiment, where power, current and voltage measurements are available every 0.01 ms. In general terms, measurements would only be required at a rate of about once every 0.1 s to track the changes. However sudden changes in the resonant characteristic 65 can occur, which the frequency control module 55 cannot track. When this happens, the frequency control module 55 resets the operating frequency to a value where it knows that it will be on one side of the characteristic.


As the impedance of the resonant circuit 28 increases sharply both above and below resonance, it is possible to operate the RF drive circuit 20 either above or below the resonant frequency. In this embodiment, the frequency control module 55 controls the operation of the drive circuit 20 so that it operates slightly above the resonant frequency as this should lead to lower switching losses through the FETs 23.



FIG. 7 illustrates the processing performed in this embodiment by the calculation module 53 and the frequency control module 55. As shown, at the beginning of the process in step s1, the control module 55 turns on the RF drive signal at the system defined maximum frequency by passing an initialisation signal to the square wave generation module 63. Provided the control module 55 has not received, in step s3, a power down signal from the medical device control module 57, the processing proceeds to step s5 where the calculation module 53 obtains the voltage and current samples from the synchronous sampling circuitry 51. In step s7 the calculation module 53 calculates the square of the voltage and the square of the current and the delivered power by multiplying the measured voltage by the measured current. These calculated values are then passed to the frequency control module 55 which compares, in step s9, the values with the defined limits for the applied voltage, current and power. The voltage and current limits are static limits that are defined in advance. However, the power limit depends on the medical procedure and is defined by the power set point (Pset) provided by the medical device control module 57. If each of the measured values is below the corresponding limit then, in step s11, the frequency control module 55 decides to decrease the drive frequency and a decrease command is passed to the square wave generator 63. At the start of the processing, the drive frequency is set to a defined maximum value (in this embodiment 500 kHz), which will always be above the resonant peak of the characteristic 65, regardless of the load impedance. Therefore, regardless of the load 39, the initial operating frequency should be on the right hand side of the resonant plot shown in FIG. 6. By decreasing the drive frequency, the drive frequency will get closer to the resonant frequency of the resonant circuit 28. As a result, the applied current will increase and more power will be delivered to the load 39. The processing then returns to step s3 and the above process is repeated.


Therefore, the current and power applied to the load 39 should increase until one of the limits is reached. At this point, the control module 55 will determine, in step s9, that a limit has been reached and so will proceed to step s13, where the control module 55 decides to increase the drive frequency and sends the square wave generation module 63 an increase command. This will cause the drive frequency to move away from the resonant frequency of the circuit 28 and so the current and power delivered to the load 39 will reduce. The processing will then return to step s3 as before.


Thus, by starting on one side of the resonant peak and slowly moving the drive frequency towards and away from the resonant peak, the current and power level applied to the load 39 can be controlled within the defined limits even as the impedance of the load changes and the resonant characteristic 65 of the resonant circuit 28 changes as the tissue/vessel is cauterised.


As those skilled in the art will appreciate, it would also be possible to start on the left hand side of the resonant peak and increase the drive frequency to increase the delivered power and decrease the drive frequency to decrease the delivered power.


Medical Device Control Module


As mentioned above, the medical device control module 57 controls the general operation of the cauterisation device 1. It receives user inputs via the user input module 59. These inputs may specify that the jaws of the forceps 9 are now gripping a vessel or tissue and that the user wishes to begin cauterisation. In response, in this embodiment, the medical device control module 57 initiates a cauterisation control procedure. Initially, the medical device control module 57 sends an initiation signal to the frequency control module 55 and obtains current and power measurements from the calculation module 53. The medical device control module 57 then checks the obtained values to make sure that the load 39 is not open circuit or short circuit. If it is not, then the medical device control module 57 starts to vary the power set point to perform the desired cauterisation. FIG. 8 is a plot illustrating the way in which the medical device control module 57 may vary the set point power to achieve the desired cauterisation procedure. Various other techniques and other power delivery algorithms may also be used.


As shown in FIG. 8, during an initial period 71 the medical device control module 57 pulses the set point power between zero and about 10 Watts. Then during a main cauterisation period 73 (which typically lasts for about 5 seconds) the medical device control module 57 pulses the set point power between zero and 50 Watts. During this period, the medical control device receives the power and voltage measurements from the calculation module 53 and calculates from them the impedance of the load 39. The medical device control module 57 determines that the cauterisation is complete when the calculated impedance exceeds a threshold. Finally, the medical device control module 57 performs a terminating procedure during a terminating period 75. During the terminating procedure, the medical device control module 57 varies the set point power and checks that cauterisation has been achieved (by checking the impedance of the load using the measured power and current values) and re-enters the main cauterisation period again if it determines that cauterisation has not been completed.


Resonant Circuit Design


The way that the values of the inductors and capacitors were chosen in this embodiment will now be described. As those skilled in the art will appreciate, other design methodologies may be used.


The complex impedance of the circuit shown in FIG. 2 can be approximated by the following equation:









Z
=


j





2





π






fL
s


+

1

j





2





π






fC
s



+


j





2





π






fL
m



R
load_ref




j





2





π






fL
m


+

R
load_ref



+

R
s






(
1
)







Where:


Rload_ref is the load resistance referred to the primary (by the square of the turns ratio); Rs represents the equivalent series resistance of the inductor, transformer capacitor and switching devices.


All other component non-idealities are ignored and the transformer is considered to be ideal as a first approximation.


Assuming that Rs is small, when the load is open circuit (ie Rload_ref is infinite) the resonant frequency can be shown to be:










f
min

=

1

2





π




(


L
s

+

L
m


)



C
s









(
2
)







Similarly, when the load is short circuit (ie Rload_ref is zero) the resonant frequency can be shown to be:










f
max

=

1

2





π




L
s



C
s









(
3
)







Assuming Rs is small, at each frequency between fmin and fmax there is a value of the load, Rload, at which the greatest power can be dissipated in the load. This maximum power can be shown to be large at frequencies near fmin and fmax, and has a minimum at the critical frequency, fc. We refer to this power as Pmax_fc- Starting with (1) it can be shown that the following relationship holds:










L
m

=


2






V
s
2



2





π






f
c



P
max_fc







(
4
)








where Vs is the supply voltage.


It can be shown that the load at which equation (4) holds is given by:

Rload_ref=2πfLm  (5)


Furthermore from (1) a relationship between fmin, fc and fmax can be established:










f
min

=




(

2





π






f
c


)

2






(

2





π






f
max


)

2

+


(

2





π






f
c


)

2




3



(

2





π






f
max


)

2


-


(

2





π






f
c


)

2









(
6
)







From (6) it can be shown that fmin,<fc<fmax. If the circuit is to operate at fc, then equation (4) gives an upper bound non the worst-case power delivered across a range of loads.


From (1), it can be shown that the efficiency of the circuit at resonance may be written as:












η
=




(




(

2





π






f
c


)

2



L
m
2



R
load






(

2





π






f
c


)

2



L
m
2


+

R
load
2



)


Re


(
Z
)









=






(

2





π






f
c


)

2



L
m
2



R
load_ref





R
s



(




(

2





π






f
c


)

2



L
m
2


+

R
load_ref
2


)


+



(

2





π






f
c


)

2



L
m
2



R
load_ref











(
7
)







From (7) it may be shown that the efficiency is a maximum when Rload_ref=2πfLm, i.e. when (5) holds. Therefore the system is designed to operate around the point of maximum efficiency.


Design Procedure


For this specific embodiment of the design the following parameters were chosen:


Battery voltage of 24V however battery voltage droops with discharge and load so Vs_sq=18V (square wave peak to peak voltage) when used


Pload=45 W (maximum power into the load)


Vload=85 Vrms (maximum voltage into the load)


Iload=1.4 Arms (maximum current into the load)


fc=430 kHz (centre or critical switching frequency)


fmax=500 kHz (maximum switching frequency, which is the upper resonant frequency)


fmin=380 kHz (approximate minimum switching frequency—needs to be calculated)


Given these values, fmin can be computed using (6):







f
min

=




(

2





π





430





k

)

2






(

2





π





500





k

)

2

+


(

2





π





430





k

)

2




3



(

2





π





500





k

)

2


-


(

2





π





430





k

)

2












f
min

=

377





kHz





Resonant circuits produce sinusoidal waveforms therefore the input square wave voltage (Vs_sq) needs to be converted into the RMS of the fundamental switching frequency (Vs).










V
s

=




4
π



Vs_sq

2


2










=




4
π




18





V


2


2










=



8.1






V
rms









The power into the load (Pload) is set by Lm. Using (4) the transformer magnetising inductance (Lm) can be determined. This ensures that at the critical frequency, fc, the required power is delivered:










L
m

=




2






V
s
2



2





π






f
c



P
load









=




2
×
8.1






V
rms
2




2





π
×
430





kHz
×
45





W













=



1.08





µH








Ls can then be calculated (derived from equations 2& 3):










L
s

=




L
m




f
max
2


f
min
2


-
1








=




1.08





µH





500





kHz


377





kHz


-
1













=



1.43





µH








Following from this Cs can be calculated (from equation 3):










C
s

=



1



L
s



(

2





π






f
max


)


2








=



1

1.43







µH


(

2





π





500





kHz

)


2









=



71





nF








To maintain regulation, the circuit is run above resonance so actual values of Cs will be typically 20% higher to bring the operating point back down (if below resonance was chosen Cs would have to be reduced).


As previously mentioned, the efficiency is maximized when Rload_ref is equal to the magnetising reactance at the critical frequency (equation 5). It is desirable, therefore, to operate about the middle of the constant power range (shown in FIG. 5b). Rload_upper is the load resistance at which constant power changes to constant voltage. Similarly, Rload_lower is the load resistance at which constant power changes to constant current.










R
load_upper

=




V
load
2

P







=




85






V
rms
2



45





W








=



161





Ω














R
load_lower

=



P

I
load
2








=




45





W


1.4






A
2









=



23





Ω








Take the geometric mean of these load resistances to find Rload_c (centre or critical load resistance)










R
load_c

=





R
load_upper



R
load_lower









=



60





Ω








As discussed, for maximum efficiency, Rload_ref should match the impedance of the primary-referred magnetising reactance at fc. Hence, Rload should equal the secondary-referred magnetising reactance Lsec can therefore be calculated as follows:










L
sec

=




R
load_c


2





π






f
c









=



60

2





π





430





kHz








=



22.2





µH








Finally the transformer turns ratio can be calculated:









N
=





L
sec


L
m









=





22.2





µH


1.08





µH









=


4.5







For any particular design it may be necessary to adjust the values due to the following reasons:

  • to maximise efficiency
  • compensate non ideal effect of components (e.g. series resistance, parasitic capacitance & inductance, non ideal transformer characteristics such as leakage inductance)
  • make the design practical (e.g. use standard values of capacitors and a whole number of turns
  • allow margin to meet the requirements due to component tolerances, temperature etc.


In this specific embodiment, the component values were optimized to:


Cs=82 nf


Lm=1.1 uH


Ls=1.4 uH


N=5 which gives Lsec≈24 uH


The following subsections briefly describe how these component values were physically implemented.


Capacitor Selection


A low loss capacitor is desired to minimise tosses and to ensure the component doesn't get too hot. Ceramic capacitors are ideal and the dielectric type of COG/NPO were used in this embodiment. The capacitor voltage rating is also important as it shouldn't be exceeded under all load conditions. Ten 250V 8.2 nF 1206 COG/NPO ceramics capacitors in parallel were used in this embodiment.


Inductor and Transformer


In this embodiment, Ferroxcube 3F3 E3216/20 a-core/plate combination was used as a ferrite core. Ferroxcube 3F3 is supplied by Ferroxcube, a subsidiary of Yageo Corporation, Taiwan. It is a high frequency ferrite material optimised for frequencies between 200 kHz and 500 kHz. By using this material the core losses are minimised. Core losses increase strongly with increasing flux density. In an inductor, for a particular required energy storage, the flux density increases with decreasing air gap (the air gap is the separation between the e-core & plate). Therefore the air gap and the number of turns can be increased to decrease core losses but this has to be balanced with the actual inductance value required and increased resistive losses introduced with the longer wire/track length.


The same issues apply to the transformer except core losses are due to the output voltage and the number of turns. Since the output voltage is fixed the number of turns is the only variable that can be changed but again this has to be balanced with resistive losses. Once the number of turns is set the air gap can then be adjusted to set Lm. Whatever core is used, it is best practise to fill the winding space with as much copper as possible to minimise resistive losses. In the transformer the' volume of windings is preferably about the same in the primary and secondary to balance the losses.


The resistive losses can usually be easily calculated but since the circuit is operating at about 400 kHz skin depth becomes an issue. The skin depth in copper at 400 kHz is only about 0.1 mm so a solid conductor thicker than this doesn't result in all the copper being used. Litz wire (stranded insulated copper wire twisted together where each strand is thinner than the skin depth) can be used to reduce this effect. In this embodiment 2 oz PCB tracks (about 0.07 mm thick copper tracks) were used for the windings of both the inductor (Ls) and the transformer to avoid having to wind custom components. The inductor had two turns with an air gap of 0.5 mm between the e-core and plate. The transformer had one turn on the primary and five turns on the secondary with an air gap between the e-core and plate of 0.1 mm.


Modifications and Alternatives


A medical cauterisation device has been described above. As those skilled in the art will appreciate, various modifications can be made and some of these will now be described. Other modifications will be apparent to those skilled in the art.


In the above embodiment, various operating frequencies, currents, voltages etc were described. As those skilled in the art will appreciate, the exact currents, voltages, frequencies, capacitor values, inductor values etc. can all be varied depending on the application and the values described above should not be considered as limiting in any way. However, in general terms, the circuit described above has been designed to provide an RF drive signal to a medical device, where the delivered power is desired to be at least 10 W and preferably between 10 W and 200 W; the delivered voltage is desired to be at least 20 Vrms and preferably between 30 Vrms and 120 Vrms; the delivered current is designed to be at least 0.5 Arms and preferably between 1 Arms and 2 Arms; and the drive frequency is at least 50 kHz.


In the above embodiment, the resonant circuit 28 was formed from capacitor-inductor-inductor elements. As those skilled in the art will appreciate, the resonant circuit 28 can be formed from various circuit designs. FIG. 9 illustrates another resonant circuit design that can be used in other embodiments. In the design shown in FIG. 9, the resonant circuit 28 is formed from capacitor-inductor-capacitor elements, with the load being connected across the second capacitor 78. As shown, in this design, there is no transformer and so there is no step-up in voltage. However, the operation of this embodiment would still be the same as in the embodiment described above and so a further description shall be omitted. Other resonant circuit designs with multiple capacitors and inductors in various series and parallel configurations or simpler LC resonant circuits may also be used.



FIG. 1 illustrates one way in which the batteries and the control electronics can be mounted within the handle of the medical device. As those skilled in the art will appreciate, the form factor of the handle may take many different designs.


In the above embodiment, an exemplary control algorithm for performing the cauterisation of the vessel or tissue gripped by the forceps was described. As those skilled in the art will appreciate, various different procedures may be used and the reader is referred to the literature describing the operation of cauterisation devices for further details


In the above embodiment, the RF drive signal generated by the drive circuitry was directly applied to the two forceps jaws of the medical device. In an alternative embodiment, the drive signal may be applied to one jaw, with the return or ground plane being provided through a separate connection on the tissue or vessel to be cauterised.


In the above embodiments, the forceps jaws were used as the electrodes of the medical device. In an alternative device, the electrodes may be provided separately from the jaws.


In the above embodiments, two FET switches were used to convert the DC voltage provided by the batteries into an alternating signal at the desired RF frequency. As those skilled in the art will appreciate, it is not necessary to use two switches—one switch may be used instead or multiple switches may be used connected, for example, in a bridge configuration. Additionally, although FET switches were used, other switching devices, such as bipolar switches may be used instead. However, MOSFETs are preferred due to their superior performance in terms of low losses when operating at the above described frequencies and current levels.


In the above embodiment, the resonant circuit 28 acted as a frequency dependent attenuator. The resonant circuit was designed as a substantially lossless attenuator, but this is not essential The resonant circuit may include lossy components as well, although the resulting circuit will of course be less efficient.


In the above embodiment, the I & Q sampling circuitry 51 sampled the sensed voltage/current signal once every period and combined samples from adjacent periods. As those skilled in the art will appreciate, this is not essential. Because of the synchronous nature of the sampling, samples may be taken more than once per period or once every nth period if desired. The sampling rate used in the above embodiment was chosen to maximise the rate at which measurements were made available to the medical device control module 57 as this allows for better control of the applied power during the cauterisation process.


In the above embodiment, a 24V DC supply was provided. In other embodiments, lower DC voltage sources may be provided. In this case, a larger transformer turns ratio may be provided to increase the load voltage to a desired level or lower operating voltages may be used.


In the above embodiment, a synchronous sampling technique was used to obtain measurements of the load voltage and load current. As those skilled in the art will appreciate, this is not essential and other more conventional sampling techniques can be used instead.


In the above embodiment, the medical device was arranged to deliver a desired power to the electrodes of the end effector. In an alternative embodiment, the device may be arranged to deliver a desired current or voltage level to the electrodes of the end effector.


In the above embodiment the battery is shown integral to the medical device. In an alternative embodiment the battery may be packaged so as to clip on a bell on the surgeon or simply be placed on the Mayo stand. In this embodiment a relatively small two conductor cable would connect the battery pack to the medical device.

Claims
  • 1. A medical device comprising: a handle for gripping by a user, an end effector coupled to the handle and having at least one electrical contact;a radio frequency (RF) generation circuit coupled to the handle and operable to generate an RF drive signal and to provide the RF drive signal to the at least one electrical contact, wherein the RF generation circuit comprises a resonant circuit; anda control circuit comprising a sampling circuit, wherein the control circuit is configured to vary a frequency of the RF drive signal around a resonant frequency of the resonant circuit and configured to determine the frequency and a phase of the RF drive signal and generate a sampling frequency, and wherein the sampling circuit is configured to sample a sensed voltage signal or a sensed current signal at the sampling frequency, such that the sampling frequency is synchronized with the frequency and the phase of the RF drive signal.
  • 2. The device according to claim 1, wherein the RF generation circuit comprises switching circuitry configured to generate a cyclically varying signal from a DC supply and wherein the resonant circuit is configured to receive the cyclically varying signal.
  • 3. The device according to claim 2, wherein the cyclically varying signal is a square wave signal.
  • 4. The device according to claim 1 comprising a battery compartment for holding one or more batteries for providing power to the RF generation circuit for generating the RF drive signal.
  • 5. The device according to claim 4, wherein the battery compartment is configured to hold a module comprising the one or more batteries and the RF generation circuit.
  • 6. The device according to claim 1, further comprising: battery terminals for connecting to one or more batteries;wherein the RF generation circuit is coupled to the battery terminals;wherein the RF generation circuit further comprises:switching circuitry for generating a cyclically varying signal from a potential difference across the battery terminals; andthe resonant circuit, being a resonant drive circuit coupled to the switching circuitry and operable to filter the cyclically varying signal generated by the switching circuitry; and wherein the RF drive signal is controlled by an output from the resonant drive circuit.
  • 7. The device according to claim 1, wherein the control circuit is operable to receive a measurement of the RF drive signal and is operable to vary the frequency of the RF drive signal to control a power, a voltage or a current delivered to the at least one electrical contact of the end effector.
  • 8. The device according to claim 7, wherein the measurement is obtained from the sampling circuit.
  • 9. The device according to claim 1, wherein the control circuit is further configured to generate the sampling frequency as an integer fraction of the frequency of the RF drive signal.
  • 10. The device according to claim 1, wherein the resonant circuit has a resonant characteristic, the resonant characteristic varying with a load connected to the at least one electrical contact, and wherein the control circuit is configured to vary the frequency of the RF drive signal to track changes in the resonant characteristic of the resonant circuit.
  • 11. A medical device comprising: a handle for gripping by a user;an end effector coupled to the handle and having at least one electrical contact;a radio frequency (RF) generation circuit operable to generate an RF drive signal and to provide the RF drive signal to the at least one electrical contact;a frequency dependent attenuator comprising a resonant circuit; anda control circuit comprising a sampling circuit, wherein the control circuit is operable to vary a frequency of the RF drive signal around a resonant frequency of the resonant circuit to control at least one of a power, a voltage or a current provided to the at least one contact of the end effector and is configured to determine the frequency and a phase of the RF drive signal and generate a sampling frequency, and wherein the sampling circuit is configured to sample a sensed voltage signal or a sensed current signal at the sampling frequency, such that the sampling frequency is synchronized with the frequency and the phase of the RF drive signal.
  • 12. The device according to claim 11, wherein the RF generation circuit comprises a signal generator operable to generate a cyclically varying signal at a frequency; and the frequency dependent attenuator is configured to attenuate the cyclically varying signal in dependence upon the frequency of the cyclically varying signal.
  • 13. The device according to claim 12, wherein the resonant frequency is at or near the frequency of the cyclically varying signal.
  • 14. The device according to claim 11, further comprising: an input for receiving a sensed signal that varies with the RF drive signal applied to the at least one electrical contact; anda measurement circuit operable to make measurements of the RF drive signal using samples obtained from the sampling circuit;wherein the control circuit is operable to control the RF generation circuit in dependence upon the measurements made by the measurement circuit, to vary the frequency of the RF drive signal.
Priority Claims (1)
Number Date Country Kind
1008510.8 May 2010 GB national
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/GB2011/000778 5/20/2011 WO 00 9/11/2013
Publishing Document Publishing Date Country Kind
WO2011/144911 11/24/2011 WO A
US Referenced Citations (1220)
Number Name Date Kind
969528 Disbrow Sep 1910 A
1570025 Young Jan 1926 A
1813902 Bovie Jul 1931 A
2442966 Wallace Jun 1948 A
2704333 Calosi et al. Mar 1955 A
2736960 Armstrong Mar 1956 A
2849788 Creek Sep 1958 A
2874470 Richards Feb 1959 A
2990616 Balamuth et al. Jul 1961 A
RE25033 Balamuth et al. Aug 1961 E
3015961 Roney Jan 1962 A
3053124 Balamuth et al. Sep 1962 A
3082805 Royce Mar 1963 A
3432691 Shoh Mar 1969 A
3433226 Boyd Mar 1969 A
3489930 Shoh Jan 1970 A
3513848 Winston et al. May 1970 A
3526219 Balamuth Sep 1970 A
3554198 Tatoian et al. Jan 1971 A
3614484 Shoh Oct 1971 A
3616375 Inoue Oct 1971 A
3629726 Popescu Dec 1971 A
3636943 Balamuth Jan 1972 A
3668486 Silver Jun 1972 A
3702948 Balamuth Nov 1972 A
3776238 Peyman et al. Dec 1973 A
3805787 Banko Apr 1974 A
3809977 Balamuth et al. May 1974 A
3830098 Antonevich Aug 1974 A
3854737 Gilliam, Sr. Dec 1974 A
3862630 Balamuth Jan 1975 A
3875945 Friedman Apr 1975 A
3885438 Harris, Sr. et al. May 1975 A
3900823 Sokal et al. Aug 1975 A
3918442 Nikolaev et al. Nov 1975 A
3924335 Balamuth et al. Dec 1975 A
3946738 Newton et al. Mar 1976 A
3955859 Stella et al. May 1976 A
3956826 Perdreaux, Jr. May 1976 A
4012647 Balamuth et al. Mar 1977 A
4074719 Semm Feb 1978 A
4156187 Murry et al. May 1979 A
4167944 Banko Sep 1979 A
4188927 Harris Feb 1980 A
4200106 Douvas et al. Apr 1980 A
4203444 Bonnell et al. May 1980 A
4300083 Heiges Nov 1981 A
4302728 Nakamura Nov 1981 A
4306570 Matthews Dec 1981 A
4445063 Smith Apr 1984 A
4491132 Aikins Jan 1985 A
4494759 Kieffer Jan 1985 A
4504264 Kelman Mar 1985 A
4512344 Barber Apr 1985 A
4526571 Wuchinich Jul 1985 A
4545374 Jacobson Oct 1985 A
4574615 Bower et al. Mar 1986 A
4617927 Manes Oct 1986 A
4633119 Thompson Dec 1986 A
4634420 Spinosa et al. Jan 1987 A
4640279 Beard Feb 1987 A
4641053 Takeda Feb 1987 A
4646738 Trott Mar 1987 A
4646756 Watmough et al. Mar 1987 A
4649919 Thimsen et al. Mar 1987 A
4662068 Polonsky May 1987 A
4674502 Imonti Jun 1987 A
4708127 Abdelghani Nov 1987 A
4712722 Hood et al. Dec 1987 A
4819635 Shapiro Apr 1989 A
4827911 Broadwin et al. May 1989 A
4832683 Idemoto et al. May 1989 A
4836186 Scholz Jun 1989 A
4838853 Parisi Jun 1989 A
4844064 Thimsen et al. Jul 1989 A
4850354 McGurk-Burleson et al. Jul 1989 A
4852578 Companion et al. Aug 1989 A
4865159 Jamison Sep 1989 A
4867157 McGurk-Burleson et al. Sep 1989 A
4878493 Pasternak et al. Nov 1989 A
4881550 Kothe Nov 1989 A
4896009 Pawlowski Jan 1990 A
4903696 Stasz et al. Feb 1990 A
4915643 Samejima et al. Apr 1990 A
4922902 Wuchinich et al. May 1990 A
4965532 Sakurai Oct 1990 A
4979952 Kubota et al. Dec 1990 A
4981756 Rhandhawa Jan 1991 A
5013956 Kurozumi et al. May 1991 A
5015227 Broadwin et al. May 1991 A
5026370 Lottick Jun 1991 A
5026387 Thomas Jun 1991 A
5042707 Taheri Aug 1991 A
5084052 Jacobs Jan 1992 A
5105117 Yamaguchi Apr 1992 A
5109819 Custer et al. May 1992 A
5112300 Ureche May 1992 A
5123903 Quaid et al. Jun 1992 A
5126618 Takahashi et al. Jun 1992 A
D327872 McMills et al. Jul 1992 S
5152762 McElhenney Oct 1992 A
5162044 Gahn et al. Nov 1992 A
5163421 Bernstein et al. Nov 1992 A
5163537 Radev Nov 1992 A
5167725 Clark et al. Dec 1992 A
5174276 Crockard Dec 1992 A
D332660 Rawson et al. Jan 1993 S
5176677 Wuchinich Jan 1993 A
5176695 Dulebohn Jan 1993 A
5184605 Grzeszykowski Feb 1993 A
5188102 Idemoto et al. Feb 1993 A
D334173 Liu et al. Mar 1993 S
5209719 Baruch et al. May 1993 A
5213569 Davis May 1993 A
5214339 Naito May 1993 A
5218529 Meyer et al. Jun 1993 A
5221282 Wuchinich Jun 1993 A
5226909 Evans et al. Jul 1993 A
5226910 Kajiyama et al. Jul 1993 A
5241236 Sasaki et al. Aug 1993 A
5241968 Slater Sep 1993 A
5242460 Klein et al. Sep 1993 A
5254129 Alexander Oct 1993 A
5257988 L'Esperance, Jr. Nov 1993 A
5261922 Hood Nov 1993 A
5263957 Davison Nov 1993 A
5264925 Shipp et al. Nov 1993 A
5275166 Vaitekunas et al. Jan 1994 A
5275609 Pingleton et al. Jan 1994 A
5282800 Foshee et al. Feb 1994 A
5282817 Hoogeboom et al. Feb 1994 A
5285795 Ryan et al. Feb 1994 A
5300068 Rosar et al. Apr 1994 A
5304115 Pflueger et al. Apr 1994 A
D347474 Olson May 1994 S
5312023 Green et al. May 1994 A
5312425 Evans et al. May 1994 A
5322055 Davison et al. Jun 1994 A
5324299 Davison et al. Jun 1994 A
5326013 Green et al. Jul 1994 A
5326342 Pflueger et al. Jul 1994 A
5344420 Hilal et al. Sep 1994 A
5345937 Middleman et al. Sep 1994 A
5346502 Estabrook et al. Sep 1994 A
5353474 Good et al. Oct 1994 A
5357164 Imabayashi et al. Oct 1994 A
5357423 Weaver et al. Oct 1994 A
5359994 Krauter et al. Nov 1994 A
5366466 Christian et al. Nov 1994 A
5370645 Klicek et al. Dec 1994 A
5371429 Manna Dec 1994 A
5374813 Shipp Dec 1994 A
D354564 Medema Jan 1995 S
5381067 Greenstein et al. Jan 1995 A
5387215 Fisher Feb 1995 A
5389098 Tsuruta et al. Feb 1995 A
5394187 Shipp Feb 1995 A
5396266 Brimhall Mar 1995 A
5403312 Yates et al. Apr 1995 A
5403334 Evans et al. Apr 1995 A
5408268 Shipp Apr 1995 A
D358887 Feinberg May 1995 S
5411481 Allen et al. May 1995 A
5419761 Narayanan et al. May 1995 A
5421829 Olichney et al. Jun 1995 A
5423844 Miller Jun 1995 A
5438997 Sieben et al. Aug 1995 A
5445639 Kuslich et al. Aug 1995 A
5449370 Vaitekunas Sep 1995 A
5451220 Ciervo Sep 1995 A
5456684 Schmidt et al. Oct 1995 A
5471988 Fujio et al. Dec 1995 A
5472443 Cordis et al. Dec 1995 A
5478003 Green et al. Dec 1995 A
5483501 Park et al. Jan 1996 A
5486162 Brumbach Jan 1996 A
5490860 Middle et al. Feb 1996 A
5500216 Julian et al. Mar 1996 A
5501654 Failla et al. Mar 1996 A
5505693 Mackool Apr 1996 A
5507738 Ciervo Apr 1996 A
5527331 Kresch et al. Jun 1996 A
5540693 Fisher Jul 1996 A
5558671 Yates Sep 1996 A
5562609 Brumbach Oct 1996 A
5562610 Brumbach Oct 1996 A
5573424 Poppe Nov 1996 A
5577654 Bishop Nov 1996 A
5591187 Dekel Jan 1997 A
5593414 Shipp et al. Jan 1997 A
5601601 Tal et al. Feb 1997 A
5603773 Campbell Feb 1997 A
5607436 Pratt et al. Mar 1997 A
5618304 Hart et al. Apr 1997 A
5618492 Auten et al. Apr 1997 A
5620447 Smith et al. Apr 1997 A
5626595 Sklar et al. May 1997 A
5628760 Knoepfler May 1997 A
5630420 Vaitekunas May 1997 A
D381077 Hunt Jul 1997 S
5651780 Jackson et al. Jul 1997 A
5653713 Michelson Aug 1997 A
5669922 Hood Sep 1997 A
5674235 Parisi Oct 1997 A
5678568 Uchikubo et al. Oct 1997 A
5690269 Bolanos et al. Nov 1997 A
5694936 Fujimoto et al. Dec 1997 A
5704534 Huitema et al. Jan 1998 A
5709680 Yates et al. Jan 1998 A
5711472 Bryan Jan 1998 A
5713896 Nardella Feb 1998 A
5717306 Shipp Feb 1998 A
5728130 Ishikawa et al. Mar 1998 A
5730752 Alden et al. Mar 1998 A
5733074 Stöck et al. Mar 1998 A
5741226 Strukel et al. Apr 1998 A
5766164 Mueller et al. Jun 1998 A
5772659 Becker et al. Jun 1998 A
5792135 Madhani et al. Aug 1998 A
5792138 Shipp Aug 1998 A
5792165 Klieman et al. Aug 1998 A
5805140 Rosenberg et al. Sep 1998 A
5808396 Boukhny Sep 1998 A
5810859 DiMatteo et al. Sep 1998 A
5817084 Jensen Oct 1998 A
5817119 Klieman et al. Oct 1998 A
5823197 Edwards Oct 1998 A
5827323 Klieman et al. Oct 1998 A
5828160 Sugishita Oct 1998 A
5833696 Whitfield et al. Nov 1998 A
5836897 Sakurai et al. Nov 1998 A
5836957 Schulz et al. Nov 1998 A
5843109 Mehta et al. Dec 1998 A
5851212 Zirps et al. Dec 1998 A
5858018 Shipp et al. Jan 1999 A
5873873 Smith et al. Feb 1999 A
5873882 Straub et al. Feb 1999 A
5878193 Wang et al. Mar 1999 A
5879364 Bromfield et al. Mar 1999 A
5883615 Fago et al. Mar 1999 A
5893835 Witt et al. Apr 1999 A
5897523 Wright et al. Apr 1999 A
5897569 Kellogg et al. Apr 1999 A
5903607 Tailliet May 1999 A
5904681 West, Jr. May 1999 A
5906627 Spaulding May 1999 A
5906628 Miyawaki et al. May 1999 A
5911699 Anis et al. Jun 1999 A
5916229 Evans Jun 1999 A
5929846 Rosenberg et al. Jul 1999 A
5935143 Hood Aug 1999 A
5935144 Estabrook Aug 1999 A
5938633 Beaupre Aug 1999 A
5944718 Austin et al. Aug 1999 A
5944737 Tsonton et al. Aug 1999 A
5947984 Whipple Sep 1999 A
5954736 Bishop et al. Sep 1999 A
5954746 Holthaus et al. Sep 1999 A
5957882 Nita et al. Sep 1999 A
5957943 Vaitekunas Sep 1999 A
5968007 Simon et al. Oct 1999 A
5968060 Kellogg Oct 1999 A
5974342 Petrofsky Oct 1999 A
D416089 Barton et al. Nov 1999 S
5980510 Tsonton et al. Nov 1999 A
5980546 Hood Nov 1999 A
5989274 Davison et al. Nov 1999 A
5989275 Estabrook et al. Nov 1999 A
5993465 Shipp et al. Nov 1999 A
5993972 Reich et al. Nov 1999 A
5994855 Lundell et al. Nov 1999 A
6024741 Williamson, IV et al. Feb 2000 A
6024750 Mastri et al. Feb 2000 A
6027515 Cimino Feb 2000 A
6031526 Shipp Feb 2000 A
6033375 Brumbach Mar 2000 A
6033399 Gines Mar 2000 A
6036667 Manna et al. Mar 2000 A
6036707 Spaulding Mar 2000 A
6048224 Kay Apr 2000 A
6050943 Slayton et al. Apr 2000 A
6051010 DiMatteo et al. Apr 2000 A
6056735 Okada et al. May 2000 A
6063098 Houser et al. May 2000 A
6066132 Chen et al. May 2000 A
6066151 Miyawaki et al. May 2000 A
6068627 Orszulak et al. May 2000 A
6068647 Witt et al. May 2000 A
6077285 Boukhny Jun 2000 A
6083191 Rose Jul 2000 A
6086584 Miller Jul 2000 A
6090120 Wright et al. Jul 2000 A
6096033 Tu et al. Aug 2000 A
6099542 Cohn et al. Aug 2000 A
6109500 Alli et al. Aug 2000 A
6110127 Suzuki Aug 2000 A
6113594 Savage Sep 2000 A
6117152 Huitema Sep 2000 A
6126629 Perkins Oct 2000 A
6129735 Okada et al. Oct 2000 A
6129740 Michelson Oct 2000 A
6132368 Cooper Oct 2000 A
6132448 Perez et al. Oct 2000 A
6139320 Hahn Oct 2000 A
6139561 Shibata et al. Oct 2000 A
6142615 Qiu et al. Nov 2000 A
6142994 Swanson et al. Nov 2000 A
6147560 Erhage et al. Nov 2000 A
6152902 Christian et al. Nov 2000 A
6154198 Rosenberg Nov 2000 A
6159160 Hsei et al. Dec 2000 A
6159175 Strukel et al. Dec 2000 A
6162194 Shipp Dec 2000 A
6165150 Banko Dec 2000 A
6174310 Kirwan, Jr. Jan 2001 B1
6179853 Sachse et al. Jan 2001 B1
6183426 Akisada et al. Feb 2001 B1
6193709 Miyawaki et al. Feb 2001 B1
6204592 Hur Mar 2001 B1
6205855 Pfeiffer Mar 2001 B1
6206844 Reichel et al. Mar 2001 B1
6210402 Olsen et al. Apr 2001 B1
6210403 Klicek Apr 2001 B1
6214023 Whipple et al. Apr 2001 B1
6228080 Gines May 2001 B1
6231565 Tovey et al. May 2001 B1
6233476 Strommer et al. May 2001 B1
6238366 Savage et al. May 2001 B1
6245065 Panescu et al. Jun 2001 B1
6252110 Uemura et al. Jun 2001 B1
D444365 Bass et al. Jul 2001 S
D445092 Lee Jul 2001 S
D445764 Lee Jul 2001 S
6254623 Haibel, Jr. et al. Jul 2001 B1
6257241 Wampler Jul 2001 B1
6258034 Hanafy Jul 2001 B1
6267761 Ryan Jul 2001 B1
6270831 Kumar et al. Aug 2001 B2
6273852 Lehe et al. Aug 2001 B1
6274963 Estabrook et al. Aug 2001 B1
6277115 Saadat Aug 2001 B1
6278218 Madan et al. Aug 2001 B1
6280407 Manna et al. Aug 2001 B1
6283981 Beaupre Sep 2001 B1
6287344 Wampler et al. Sep 2001 B1
6290575 Shipp Sep 2001 B1
6306157 Shchervinsky Oct 2001 B1
6309400 Beaupre Oct 2001 B2
6319221 Savage et al. Nov 2001 B1
6325795 Lindemann et al. Dec 2001 B1
6325799 Goble Dec 2001 B1
6325811 Messerly Dec 2001 B1
6328751 Beaupre Dec 2001 B1
6332891 Himes Dec 2001 B1
6338657 Harper et al. Jan 2002 B1
6340352 Okada et al. Jan 2002 B1
6350269 Shipp et al. Feb 2002 B1
6352532 Kramer et al. Mar 2002 B1
6358264 Banko Mar 2002 B2
6364888 Niemeyer et al. Apr 2002 B1
6379320 Lafon et al. Apr 2002 B1
D457958 Dycus et al. May 2002 S
6383194 Pothula May 2002 B1
6384690 Wilhelmsson et al. May 2002 B1
6387109 Davison et al. May 2002 B1
6388657 Natoli May 2002 B1
6391042 Cimino May 2002 B1
6398779 Buysse et al. Jun 2002 B1
6402743 Orszulak et al. Jun 2002 B1
6402748 Schoenman et al. Jun 2002 B1
6405733 Fogarty et al. Jun 2002 B1
6416486 Wampler Jul 2002 B1
6423073 Bowman Jul 2002 B2
6423082 Houser et al. Jul 2002 B1
6428539 Baxter et al. Aug 2002 B1
6432118 Messerly Aug 2002 B1
6436114 Novak et al. Aug 2002 B1
6436115 Beaupre Aug 2002 B1
6440062 Ouchi Aug 2002 B1
6443968 Holthaus et al. Sep 2002 B1
6443969 Novak et al. Sep 2002 B1
6449006 Shipp Sep 2002 B1
6454781 Witt et al. Sep 2002 B1
6454782 Schwemberger Sep 2002 B1
6458142 Faller et al. Oct 2002 B1
6475215 Tanrisever Nov 2002 B1
6480796 Wiener Nov 2002 B2
6485490 Wampler et al. Nov 2002 B2
6491708 Madan et al. Dec 2002 B2
6497715 Satou Dec 2002 B2
6500176 Truckai et al. Dec 2002 B1
6500188 Harper et al. Dec 2002 B2
6500312 Wedekamp Dec 2002 B2
6506208 Hunt et al. Jan 2003 B2
6511478 Burnside et al. Jan 2003 B1
6511493 Moutafis et al. Jan 2003 B1
6514267 Jewett Feb 2003 B2
6524251 Rabiner et al. Feb 2003 B2
6524316 Nicholson et al. Feb 2003 B1
6527736 Attinger et al. Mar 2003 B1
6533784 Truckai et al. Mar 2003 B2
6537272 Christopherson et al. Mar 2003 B2
6537291 Friedman et al. Mar 2003 B2
6543452 Lavigne Apr 2003 B1
6543456 Freeman Apr 2003 B1
6544260 Markel et al. Apr 2003 B1
6558376 Bishop May 2003 B2
6561983 Cronin et al. May 2003 B2
6565558 Lindenmeier et al. May 2003 B1
6572563 Ouchi Jun 2003 B2
6572632 Zisterer et al. Jun 2003 B2
6575969 Rittman, III et al. Jun 2003 B1
6582427 Goble et al. Jun 2003 B1
6582451 Marucci et al. Jun 2003 B1
D477408 Bromley Jul 2003 S
6588277 Giordano et al. Jul 2003 B2
6589200 Schwemberger et al. Jul 2003 B1
6589239 Khandkar et al. Jul 2003 B2
6607540 Shipp Aug 2003 B1
6610059 West, Jr. Aug 2003 B1
6616450 Mossle et al. Sep 2003 B2
6619529 Green et al. Sep 2003 B2
6623500 Cook et al. Sep 2003 B1
6623501 Heller et al. Sep 2003 B2
6626848 Neuenfeldt Sep 2003 B2
6626926 Friedman et al. Sep 2003 B2
6629974 Penny et al. Oct 2003 B2
6633234 Wiener et al. Oct 2003 B2
6644532 Green et al. Nov 2003 B2
6652513 Panescu et al. Nov 2003 B2
6652539 Shipp et al. Nov 2003 B2
6652545 Shipp et al. Nov 2003 B2
6656132 Ouchi Dec 2003 B1
6656177 Truckai et al. Dec 2003 B2
6660017 Beaupre Dec 2003 B2
6662127 Wiener et al. Dec 2003 B2
6663941 Brown et al. Dec 2003 B2
6666860 Takahashi Dec 2003 B1
6666875 Sakurai et al. Dec 2003 B1
6669690 Okada et al. Dec 2003 B1
6669710 Moutafis et al. Dec 2003 B2
6676660 Wampler et al. Jan 2004 B2
6678621 Wiener et al. Jan 2004 B2
6679875 Honda et al. Jan 2004 B2
6679899 Wiener et al. Jan 2004 B2
6682544 Mastri et al. Jan 2004 B2
6685701 Orszulak et al. Feb 2004 B2
6685703 Pearson et al. Feb 2004 B2
6689145 Lee et al. Feb 2004 B2
6689146 Himes Feb 2004 B1
6716215 David et al. Apr 2004 B1
6719692 Kleffner et al. Apr 2004 B2
6719776 Baxter Apr 2004 B2
6723091 Goble et al. Apr 2004 B2
D490059 Conway et al. May 2004 S
6731047 Kauf et al. May 2004 B2
6733506 McDevitt et al. May 2004 B1
6739872 Turri May 2004 B1
6740079 Eggers et al. May 2004 B1
D491666 Kimmell et al. Jun 2004 S
6743245 Lobdell Jun 2004 B2
6746284 Spink, Jr. Jun 2004 B1
6746443 Morley et al. Jun 2004 B1
6752815 Beaupre Jun 2004 B2
6755825 Shoenman et al. Jun 2004 B2
6761698 Shibata et al. Jul 2004 B2
6762535 Take et al. Jul 2004 B2
6770072 Truckai et al. Aug 2004 B1
6773409 Truckai et al. Aug 2004 B2
6773443 Truwit et al. Aug 2004 B2
6773444 Messerly Aug 2004 B2
6778023 Christensen Aug 2004 B2
6783524 Anderson et al. Aug 2004 B2
6786382 Hoffman Sep 2004 B1
6786383 Stegelmann Sep 2004 B2
6790173 Saadat et al. Sep 2004 B2
6790216 Ishikawa Sep 2004 B1
6796981 Wham et al. Sep 2004 B2
D496997 Dycus et al. Oct 2004 S
6802843 Truckai et al. Oct 2004 B2
6809508 Donofrio Oct 2004 B2
6810281 Brock et al. Oct 2004 B2
6827712 Tovey et al. Dec 2004 B2
6828712 Battaglin et al. Dec 2004 B2
6835082 Gonnering Dec 2004 B2
6849073 Hoey et al. Feb 2005 B2
6860878 Brock Mar 2005 B2
6863676 Lee et al. Mar 2005 B2
6869439 White et al. Mar 2005 B2
6875220 Du et al. Apr 2005 B2
6877647 Green et al. Apr 2005 B2
6882439 Ishijima Apr 2005 B2
6887209 Kadziauskas et al. May 2005 B2
6887252 Okada et al. May 2005 B1
6899685 Kermode et al. May 2005 B2
6905497 Truckai et al. Jun 2005 B2
6908472 Wiener et al. Jun 2005 B2
6913579 Truckai et al. Jul 2005 B2
6915623 Dey et al. Jul 2005 B2
6923804 Eggers et al. Aug 2005 B2
6926712 Phan Aug 2005 B2
6926716 Baker et al. Aug 2005 B2
6929602 Hirakui et al. Aug 2005 B2
6929632 Nita et al. Aug 2005 B2
6929644 Truckai et al. Aug 2005 B2
6933656 Matsushita et al. Aug 2005 B2
D509589 Wells Sep 2005 S
6942660 Pantera et al. Sep 2005 B2
6942677 Nita et al. Sep 2005 B2
6945981 Donofrio et al. Sep 2005 B2
6946779 Birgel Sep 2005 B2
6948503 Refior et al. Sep 2005 B2
D511145 Donofrio et al. Nov 2005 S
6974450 Weber et al. Dec 2005 B2
6976844 Hickok et al. Dec 2005 B2
6976969 Messerly Dec 2005 B2
6977495 Donofrio Dec 2005 B2
6979332 Adams Dec 2005 B2
6981628 Wales Jan 2006 B2
6984220 Wuchinich Jan 2006 B2
6994708 Manzo Feb 2006 B2
7001335 Adachi et al. Feb 2006 B2
7011657 Truckai et al. Mar 2006 B2
7014638 Michelson Mar 2006 B2
7033357 Baxter et al. Apr 2006 B2
7037306 Podany May 2006 B2
7041083 Chu et al. May 2006 B2
7041088 Nawrocki et al. May 2006 B2
7041102 Truckai et al. May 2006 B2
7044949 Orszulak et al. May 2006 B2
7066893 Hibner et al. Jun 2006 B2
7066895 Podany Jun 2006 B2
7070597 Truckai et al. Jul 2006 B2
7074218 Washington et al. Jul 2006 B2
7074219 Levine et al. Jul 2006 B2
7077039 Gass et al. Jul 2006 B2
7077845 Hacker et al. Jul 2006 B2
7077853 Kramer et al. Jul 2006 B2
7083619 Truckai et al. Aug 2006 B2
7087054 Truckai et al. Aug 2006 B2
7090672 Underwood et al. Aug 2006 B2
7101371 Dycus et al. Sep 2006 B2
7101378 Salameh et al. Sep 2006 B2
7104834 Robinson et al. Sep 2006 B2
7108695 Witt et al. Sep 2006 B2
7111769 Wales et al. Sep 2006 B2
7112201 Truckai et al. Sep 2006 B2
D531311 Guerra et al. Oct 2006 S
7117034 Kronberg Oct 2006 B2
7118564 Ritchie et al. Oct 2006 B2
7124932 Isaacson et al. Oct 2006 B2
7125409 Truckai et al. Oct 2006 B2
7128720 Podany Oct 2006 B2
7131860 Sartor et al. Nov 2006 B2
7135018 Ryan et al. Nov 2006 B2
7135030 Schwemberger et al. Nov 2006 B2
7137980 Buysse et al. Nov 2006 B2
7144403 Booth Dec 2006 B2
7153315 Miller Dec 2006 B2
D536093 Nakajima et al. Jan 2007 S
7156189 Bar-Cohen et al. Jan 2007 B1
7156853 Muratsu Jan 2007 B2
7157058 Marhasin et al. Jan 2007 B2
7159750 Racenet et al. Jan 2007 B2
7160296 Pearson et al. Jan 2007 B2
7160299 Baily Jan 2007 B2
7163548 Stulen et al. Jan 2007 B2
7169144 Hoey et al. Jan 2007 B2
7169146 Truckai et al. Jan 2007 B2
7179254 Pendekanti et al. Feb 2007 B2
7179271 Friedman et al. Feb 2007 B2
7186253 Truckai et al. Mar 2007 B2
7189233 Truckai et al. Mar 2007 B2
D541418 Schechter et al. Apr 2007 S
7204820 Akahoshi Apr 2007 B2
7207997 Shipp et al. Apr 2007 B2
7210881 Greenberg May 2007 B2
7211079 Treat May 2007 B2
7217128 Atkin et al. May 2007 B2
7217269 El-Galley et al. May 2007 B2
7220951 Truckai et al. May 2007 B2
7223229 Inman et al. May 2007 B2
7229455 Sakurai et al. Jun 2007 B2
7235071 Gonnering Jun 2007 B2
7244262 Wiener et al. Jul 2007 B2
7258688 Shah et al. Aug 2007 B1
7269873 Brewer et al. Sep 2007 B2
7273483 Wiener et al. Sep 2007 B2
D552241 Bromley et al. Oct 2007 S
7282048 Goble et al. Oct 2007 B2
7285895 Beaupré Oct 2007 B2
7300431 Dubrovsky Nov 2007 B2
7300435 Wham et al. Nov 2007 B2
7300446 Beaupre Nov 2007 B2
7303531 Lee et al. Dec 2007 B2
7303557 Wham et al. Dec 2007 B2
7309849 Truckai et al. Dec 2007 B2
7311706 Schoenman et al. Dec 2007 B2
7311709 Truckai et al. Dec 2007 B2
7317955 McGreevy Jan 2008 B2
7318831 Alvarez et al. Jan 2008 B2
7326236 Andreas et al. Feb 2008 B2
7331410 Yong et al. Feb 2008 B2
7335165 Truwit et al. Feb 2008 B2
7335997 Wiener Feb 2008 B2
7337010 Howard et al. Feb 2008 B2
7353068 Tanaka et al. Apr 2008 B2
7354440 Truckal et al. Apr 2008 B2
7364577 Wham et al. Apr 2008 B2
RE40388 Gines Jun 2008 E
7380695 Doll et al. Jun 2008 B2
7380696 Shelton, IV et al. Jun 2008 B2
7381209 Truckai et al. Jun 2008 B2
7390317 Taylor et al. Jun 2008 B2
7404508 Smith et al. Jul 2008 B2
7408288 Hara Aug 2008 B2
7416101 Shelton, IV et al. Aug 2008 B2
7416437 Sartor et al. Aug 2008 B2
D576725 Shumer et al. Sep 2008 S
7419490 Falkenstein et al. Sep 2008 B2
7422139 Shelton, IV et al. Sep 2008 B2
7422463 Kuo Sep 2008 B2
D578643 Shumer et al. Oct 2008 S
D578644 Shumer et al. Oct 2008 S
D578645 Shumer et al. Oct 2008 S
7431704 Babaev Oct 2008 B2
7441684 Shelton, IV et al. Oct 2008 B2
7455208 Wales et al. Nov 2008 B2
7462181 Kraft et al. Dec 2008 B2
7464846 Shelton, IV et al. Dec 2008 B2
7472815 Shelton, IV et al. Jan 2009 B2
7473263 Johnston et al. Jan 2009 B2
7479148 Beaupre Jan 2009 B2
7479160 Branch et al. Jan 2009 B2
7481775 Weikel, Jr. et al. Jan 2009 B2
7488285 Honda et al. Feb 2009 B2
7494468 Rabiner et al. Feb 2009 B2
7503893 Kucklick Mar 2009 B2
7503895 Rabiner et al. Mar 2009 B2
7506790 Shelton, IV Mar 2009 B2
7506791 Omaits et al. Mar 2009 B2
7524320 Tierney et al. Apr 2009 B2
7530986 Beaupre et al. May 2009 B2
7534243 Chin et al. May 2009 B1
D594983 Price et al. Jun 2009 S
7540871 Gonnering Jun 2009 B2
7544200 Houser Jun 2009 B2
7549564 Boudreaux Jun 2009 B2
7559450 Wales et al. Jul 2009 B2
7567012 Namikawa Jul 2009 B2
7569057 Liu et al. Aug 2009 B2
7572266 Young et al. Aug 2009 B2
7578820 Moore et al. Aug 2009 B2
7582084 Swanson et al. Sep 2009 B2
7582095 Shipp et al. Sep 2009 B2
7585181 Olsen Sep 2009 B2
7588176 Timm et al. Sep 2009 B2
7601119 Shahinian Oct 2009 B2
7621930 Houser Nov 2009 B2
7641653 Dalla Betta et al. Jan 2010 B2
7654431 Hueil et al. Feb 2010 B2
7659833 Warner et al. Feb 2010 B2
7665647 Shelton, IV et al. Feb 2010 B2
7670334 Hueil et al. Mar 2010 B2
7670338 Albrecht et al. Mar 2010 B2
7674263 Ryan Mar 2010 B2
7678069 Baker et al. Mar 2010 B1
7678125 Shipp Mar 2010 B2
7682366 Sakurai et al. Mar 2010 B2
7686770 Cohen Mar 2010 B2
7686826 Lee et al. Mar 2010 B2
7688028 Phillips et al. Mar 2010 B2
7691098 Wallace et al. Apr 2010 B2
7699846 Ryan Apr 2010 B2
7713202 Boukhny et al. May 2010 B2
7714481 Sakai May 2010 B2
7717915 Miyazawa May 2010 B2
D618797 Price et al. Jun 2010 S
7726537 Olson et al. Jun 2010 B2
7738969 Bleich Jun 2010 B2
7740594 Hibner Jun 2010 B2
7751115 Song Jul 2010 B2
D621503 Otten et al. Aug 2010 S
7766210 Shelton, IV et al. Aug 2010 B2
7766693 Sartor et al. Aug 2010 B2
7770774 Mastri et al. Aug 2010 B2
7770775 Shelton, IV et al. Aug 2010 B2
7771425 Dycus et al. Aug 2010 B2
7771444 Patel et al. Aug 2010 B2
7775972 Brock et al. Aug 2010 B2
7778733 Nowlin et al. Aug 2010 B2
7780054 Wales Aug 2010 B2
7780593 Ueno et al. Aug 2010 B2
7780651 Madhani et al. Aug 2010 B2
7780659 Okada et al. Aug 2010 B2
7784662 Wales et al. Aug 2010 B2
7796969 Kelly et al. Sep 2010 B2
7798386 Schall et al. Sep 2010 B2
7799020 Shores et al. Sep 2010 B2
7799045 Masuda Sep 2010 B2
7803152 Honda et al. Sep 2010 B2
7806891 Nowlin et al. Oct 2010 B2
7810693 Broehl et al. Oct 2010 B2
7819819 Quick et al. Oct 2010 B2
D627066 Romero Nov 2010 S
7824401 Manzo et al. Nov 2010 B2
7832611 Boyden et al. Nov 2010 B2
7834484 Sartor Nov 2010 B2
7837699 Yamada et al. Nov 2010 B2
7845537 Shelton, IV et al. Dec 2010 B2
7846155 Houser et al. Dec 2010 B2
7846161 Dumbauld et al. Dec 2010 B2
7854735 Houser et al. Dec 2010 B2
D631155 Peine et al. Jan 2011 S
7861906 Doll et al. Jan 2011 B2
7862560 Marion Jan 2011 B2
7876030 Taki et al. Jan 2011 B2
D631965 Price et al. Feb 2011 S
7878991 Babaev Feb 2011 B2
7879033 Sartor et al. Feb 2011 B2
7892606 Thies et al. Feb 2011 B2
7901400 Wham et al. Mar 2011 B2
7901423 Stulen et al. Mar 2011 B2
7905881 Masuda et al. Mar 2011 B2
7909824 Masuda et al. Mar 2011 B2
7922061 Shelton, IV et al. Apr 2011 B2
7922651 Yamada et al. Apr 2011 B2
D637288 Houghton May 2011 S
D638540 Ijiri et al. May 2011 S
7936203 Zimlich May 2011 B2
7951095 Makin et al. May 2011 B2
7951165 Golden et al. May 2011 B2
7959050 Smith et al. Jun 2011 B2
7959626 Hong et al. Jun 2011 B2
7972329 Refior et al. Jul 2011 B2
7976544 McClurken et al. Jul 2011 B2
7981050 Ritchart et al. Jul 2011 B2
7998157 Culp et al. Aug 2011 B2
8038693 Allen Oct 2011 B2
8057498 Robertson Nov 2011 B2
8058771 Giordano et al. Nov 2011 B2
8061014 Smith et al. Nov 2011 B2
8070711 Bassinger et al. Dec 2011 B2
8070762 Escudero et al. Dec 2011 B2
8075558 Truckai et al. Dec 2011 B2
8089197 Rinner et al. Jan 2012 B2
8097012 Kagarise Jan 2012 B2
8105323 Buysse et al. Jan 2012 B2
8142461 Houser et al. Mar 2012 B2
8152825 Madan et al. Apr 2012 B2
8157145 Shelton, IV et al. Apr 2012 B2
8161977 Shelton, IV et al. Apr 2012 B2
8162966 Connor et al. Apr 2012 B2
8172846 Brunnett et al. May 2012 B2
8172870 Shipp May 2012 B2
8177800 Spitz et al. May 2012 B2
8182502 Stulen et al. May 2012 B2
8186877 Klimovitch et al. May 2012 B2
D661801 Price et al. Jun 2012 S
D661802 Price et al. Jun 2012 S
D661803 Price et al. Jun 2012 S
D661804 Price et al. Jun 2012 S
8197502 Smith et al. Jun 2012 B2
8210411 Yates et al. Jul 2012 B2
8226675 Houser et al. Jul 2012 B2
8235917 Joseph et al. Aug 2012 B2
8236019 Houser Aug 2012 B2
8236020 Smith et al. Aug 2012 B2
8246575 Viola Aug 2012 B2
8246615 Behnke Aug 2012 B2
8252012 Stulen Aug 2012 B2
8253303 Giordano et al. Aug 2012 B2
8257377 Wiener et al. Sep 2012 B2
8257387 Cunningham Sep 2012 B2
8273087 Kimura et al. Sep 2012 B2
D669992 Schafer et al. Oct 2012 S
D669993 Merchant et al. Oct 2012 S
8286846 Smith et al. Oct 2012 B2
8287485 Kimura et al. Oct 2012 B2
8287528 Wham et al. Oct 2012 B2
8287532 Carroll et al. Oct 2012 B2
8298223 Wham et al. Oct 2012 B2
8298225 Gilbert Oct 2012 B2
8303576 Brock Nov 2012 B2
8303580 Wham et al. Nov 2012 B2
8303583 Hosier et al. Nov 2012 B2
8319400 Houser et al. Nov 2012 B2
8323302 Robertson et al. Dec 2012 B2
8333778 Smith et al. Dec 2012 B2
8333779 Smith et al. Dec 2012 B2
8334468 Palmer et al. Dec 2012 B2
8334635 Voegele et al. Dec 2012 B2
8337407 Quistgaard et al. Dec 2012 B2
8338726 Palmer et al. Dec 2012 B2
8344596 Nield et al. Jan 2013 B2
8348967 Stulen Jan 2013 B2
8357103 Mark et al. Jan 2013 B2
8372099 Deville et al. Feb 2013 B2
8372101 Smith et al. Feb 2013 B2
8372102 Stulen et al. Feb 2013 B2
8374670 Selkee Feb 2013 B2
8377059 Deville et al. Feb 2013 B2
8377085 Smith et al. Feb 2013 B2
8382782 Robertson et al. Feb 2013 B2
8403948 Deville et al. Mar 2013 B2
8403949 Palmer et al. Mar 2013 B2
8403950 Palmer et al. Mar 2013 B2
8418349 Smith et al. Apr 2013 B2
8419757 Smith et al. Apr 2013 B2
8419758 Smith et al. Apr 2013 B2
8419759 Dietz Apr 2013 B2
8425545 Smith et al. Apr 2013 B2
8430898 Wiener et al. Apr 2013 B2
8435257 Smith et al. May 2013 B2
8439912 Cunningham et al. May 2013 B2
8439939 Deville et al. May 2013 B2
8444637 Podmore et al. May 2013 B2
8444662 Palmer et al. May 2013 B2
8444664 Balanev et al. May 2013 B2
8461744 Wiener et al. Jun 2013 B2
8469981 Robertson et al. Jun 2013 B2
8479969 Shelton, IV Jul 2013 B2
8480703 Nicholas et al. Jul 2013 B2
8485413 Scheib et al. Jul 2013 B2
8486057 Behnke, II Jul 2013 B2
8486096 Robertson et al. Jul 2013 B2
8491578 Manwaring et al. Jul 2013 B2
D687549 Johnson et al. Aug 2013 S
8509318 Tailliet Aug 2013 B2
8512359 Whitman et al. Aug 2013 B2
8512365 Wiener et al. Aug 2013 B2
8523889 Stulen et al. Sep 2013 B2
8531064 Robertson et al. Sep 2013 B2
8535340 Allen Sep 2013 B2
8535341 Allen Sep 2013 B2
8546996 Messerly et al. Oct 2013 B2
8546999 Houser et al. Oct 2013 B2
8568400 Gilbert Oct 2013 B2
8573461 Shelton, IV et al. Nov 2013 B2
8573465 Shelton, IV Nov 2013 B2
8579928 Robertson et al. Nov 2013 B2
8591506 Wham et al. Nov 2013 B2
8591536 Robertson Nov 2013 B2
D695407 Price et al. Dec 2013 S
D696631 Price et al. Dec 2013 S
8602031 Reis et al. Dec 2013 B2
8602288 Shelton, IV et al. Dec 2013 B2
8608745 Guzman et al. Dec 2013 B2
8616431 Timm et al. Dec 2013 B2
8623027 Price et al. Jan 2014 B2
8650728 Wan et al. Feb 2014 B2
8652155 Houser et al. Feb 2014 B2
8659208 Rose et al. Feb 2014 B1
8663220 Wiener et al. Mar 2014 B2
8690582 Rohrbach et al. Apr 2014 B2
8696366 Chen et al. Apr 2014 B2
8704425 Giordano et al. Apr 2014 B2
8709031 Stulen Apr 2014 B2
8749116 Messerly et al. Jun 2014 B2
8752749 Moore et al. Jun 2014 B2
8754570 Voegele et al. Jun 2014 B2
8764735 Coe et al. Jul 2014 B2
8773001 Wiener et al. Jul 2014 B2
8779648 Giordano et al. Jul 2014 B2
8808319 Houser et al. Aug 2014 B2
8827992 Koss et al. Sep 2014 B2
8845537 Tanaka et al. Sep 2014 B2
8882791 Stulen Nov 2014 B2
8888776 Dietz et al. Nov 2014 B2
8888809 Davison et al. Nov 2014 B2
8900259 Houser et al. Dec 2014 B2
8911460 Neurohr et al. Dec 2014 B2
8951248 Messerly et al. Feb 2015 B2
8951272 Robertson et al. Feb 2015 B2
8956349 Aldridge et al. Feb 2015 B2
8961547 Dietz et al. Feb 2015 B2
8974477 Yamada Mar 2015 B2
8979890 Boudreaux Mar 2015 B2
8986302 Aldridge et al. Mar 2015 B2
9039695 Giordano et al. May 2015 B2
9044261 Houser Jun 2015 B2
20010025173 Ritchie et al. Sep 2001 A1
20010025183 Shahidi et al. Sep 2001 A1
20010025184 Messerly Sep 2001 A1
20010031950 Ryan Oct 2001 A1
20010039419 Francischelli et al. Nov 2001 A1
20020002377 Cimino Jan 2002 A1
20020019649 Sikora et al. Feb 2002 A1
20020022836 Goble et al. Feb 2002 A1
20020029055 Bonutti Mar 2002 A1
20020049551 Friedman et al. Apr 2002 A1
20020052617 Anis et al. May 2002 A1
20020077550 Rabiner et al. Jun 2002 A1
20020156466 Sakurai et al. Oct 2002 A1
20020156493 Houser et al. Oct 2002 A1
20030014087 Fang et al. Jan 2003 A1
20030036705 Hare et al. Feb 2003 A1
20030050572 Brautigam et al. Mar 2003 A1
20030055443 Spotnitz Mar 2003 A1
20030114851 Truckai et al. Jun 2003 A1
20030144680 Kellogg et al. Jul 2003 A1
20030199794 Sakurai et al. Oct 2003 A1
20030204199 Novak et al. Oct 2003 A1
20030212332 Fenton et al. Nov 2003 A1
20030212363 Shipp Nov 2003 A1
20030212392 Fenton et al. Nov 2003 A1
20030212422 Fenton et al. Nov 2003 A1
20030229344 Dycus et al. Dec 2003 A1
20040030254 Babaev Feb 2004 A1
20040030330 Brassell et al. Feb 2004 A1
20040047485 Sherrit et al. Mar 2004 A1
20040054364 Aranyi et al. Mar 2004 A1
20040064151 Mollenauer Apr 2004 A1
20040092921 Kadziauskas et al. May 2004 A1
20040092992 Adams et al. May 2004 A1
20040097912 Gonnering May 2004 A1
20040097919 Wellman et al. May 2004 A1
20040097996 Rabiner et al. May 2004 A1
20040116952 Sakurai et al. Jun 2004 A1
20040132383 Langford et al. Jul 2004 A1
20040147934 Kiester Jul 2004 A1
20040167508 Wham et al. Aug 2004 A1
20040176686 Hare et al. Sep 2004 A1
20040199193 Hayashi et al. Oct 2004 A1
20040204728 Haefner Oct 2004 A1
20040243147 Lipow Dec 2004 A1
20040260300 Gorensek et al. Dec 2004 A1
20050021018 Anderson et al. Jan 2005 A1
20050021065 Yamada et al. Jan 2005 A1
20050033337 Muir et al. Feb 2005 A1
20050049546 Messerly et al. Mar 2005 A1
20050070800 Takahashi Mar 2005 A1
20050096683 Ellins et al. May 2005 A1
20050099824 Dowling et al. May 2005 A1
20050103819 Racenet et al. May 2005 A1
20050143769 White et al. Jun 2005 A1
20050149108 Cox Jul 2005 A1
20050165345 Laufer et al. Jul 2005 A1
20050177184 Easley Aug 2005 A1
20050182339 Lee et al. Aug 2005 A1
20050188743 Land Sep 2005 A1
20050192610 Houser et al. Sep 2005 A1
20050209620 Du et al. Sep 2005 A1
20050222598 Ho et al. Oct 2005 A1
20050234484 Houser et al. Oct 2005 A1
20050249667 Tuszynski et al. Nov 2005 A1
20050256405 Makin et al. Nov 2005 A1
20050261581 Hughes et al. Nov 2005 A1
20050261588 Makin et al. Nov 2005 A1
20050273090 Nieman et al. Dec 2005 A1
20050288659 Kimura et al. Dec 2005 A1
20060030797 Zhou et al. Feb 2006 A1
20060058825 Ogura et al. Mar 2006 A1
20060063130 Hayman et al. Mar 2006 A1
20060066181 Bromfield et al. Mar 2006 A1
20060074442 Noriega et al. Apr 2006 A1
20060079879 Faller et al. Apr 2006 A1
20060084963 Messerly Apr 2006 A1
20060095046 Trieu et al. May 2006 A1
20060190034 Nishizawa et al. Aug 2006 A1
20060206100 Eskridge et al. Sep 2006 A1
20060206115 Schomer et al. Sep 2006 A1
20060211943 Beaupre Sep 2006 A1
20060217729 Eskridge et al. Sep 2006 A1
20060235306 Cotter et al. Oct 2006 A1
20060247558 Yamada Nov 2006 A1
20060253050 Yoshimine et al. Nov 2006 A1
20060264809 Hansmann et al. Nov 2006 A1
20070016235 Tanaka et al. Jan 2007 A1
20070016236 Beaupre Jan 2007 A1
20070055228 Berg et al. Mar 2007 A1
20070056596 Fanney et al. Mar 2007 A1
20070060915 Kucklick Mar 2007 A1
20070060935 Schwardt et al. Mar 2007 A1
20070063618 Bromfield Mar 2007 A1
20070074584 Talarico et al. Apr 2007 A1
20070106317 Shelton, IV et al. May 2007 A1
20070129716 Daw et al. Jun 2007 A1
20070130771 Ehlert et al. Jun 2007 A1
20070131034 Ehlert et al. Jun 2007 A1
20070149881 Rabin Jun 2007 A1
20070162050 Sartor Jul 2007 A1
20070166663 Telles et al. Jul 2007 A1
20070173803 Wham et al. Jul 2007 A1
20070173813 Odom Jul 2007 A1
20070173872 Neuenfeldt Jul 2007 A1
20070175949 Shelton, IV et al. Aug 2007 A1
20070185380 Kucklick Aug 2007 A1
20070191712 Messerly et al. Aug 2007 A1
20070219481 Babaev Sep 2007 A1
20070239028 Houser et al. Oct 2007 A1
20070239101 Kellogg Oct 2007 A1
20070249941 Salehi et al. Oct 2007 A1
20070260234 McCullagh et al. Nov 2007 A1
20070265560 Soltani et al. Nov 2007 A1
20070275348 Lemon Nov 2007 A1
20070282335 Young et al. Dec 2007 A1
20070287933 Phan et al. Dec 2007 A1
20070288055 Lee Dec 2007 A1
20080009848 Paraschiv et al. Jan 2008 A1
20080051812 Schmitz et al. Feb 2008 A1
20080058585 Novak et al. Mar 2008 A1
20080058775 Darian et al. Mar 2008 A1
20080058845 Shimizu et al. Mar 2008 A1
20080082039 Babaev Apr 2008 A1
20080082098 Tanaka et al. Apr 2008 A1
20080114364 Goldin et al. May 2008 A1
20080125768 Tahara et al. May 2008 A1
20080140158 Hamel et al. Jun 2008 A1
20080147092 Rogge et al. Jun 2008 A1
20080171938 Masuda et al. Jul 2008 A1
20080172051 Masuda et al. Jul 2008 A1
20080177268 Daum et al. Jul 2008 A1
20080188878 Young Aug 2008 A1
20080200940 Eichmann et al. Aug 2008 A1
20080208108 Kimura Aug 2008 A1
20080208231 Ota et al. Aug 2008 A1
20080214967 Aranyi et al. Sep 2008 A1
20080234709 Houser Sep 2008 A1
20080243106 Coe et al. Oct 2008 A1
20080243162 Shibata et al. Oct 2008 A1
20080245371 Gruber Oct 2008 A1
20080249553 Gruber et al. Oct 2008 A1
20080255423 Kondo et al. Oct 2008 A1
20080262490 Williams Oct 2008 A1
20080281200 Voic et al. Nov 2008 A1
20080281315 Gines Nov 2008 A1
20080281322 Sherman et al. Nov 2008 A1
20080287948 Newton et al. Nov 2008 A1
20090023985 Ewers Jan 2009 A1
20090048537 Lydon et al. Feb 2009 A1
20090054886 Yachi et al. Feb 2009 A1
20090054894 Yachi Feb 2009 A1
20090076506 Baker Mar 2009 A1
20090082716 Akahoshi Mar 2009 A1
20090112229 Omori et al. Apr 2009 A1
20090118751 Wiener et al. May 2009 A1
20090118802 Mioduski et al. May 2009 A1
20090138006 Bales et al. May 2009 A1
20090143799 Smith et al. Jun 2009 A1
20090143800 Deville et al. Jun 2009 A1
20090143806 Witt et al. Jun 2009 A1
20090149801 Crandall et al. Jun 2009 A1
20090207923 Dress Aug 2009 A1
20090216157 Yamada Aug 2009 A1
20090223033 Houser Sep 2009 A1
20090254077 Craig Oct 2009 A1
20090254080 Honda Oct 2009 A1
20090270771 Takahashi Oct 2009 A1
20090270812 Litscher et al. Oct 2009 A1
20090270853 Yachi et al. Oct 2009 A1
20090270899 Carusillo et al. Oct 2009 A1
20090275940 Malackowski et al. Nov 2009 A1
20090318945 Yoshimine et al. Dec 2009 A1
20090327715 Smith et al. Dec 2009 A1
20100004508 Naito et al. Jan 2010 A1
20100016785 Takuma Jan 2010 A1
20100016852 Manzo et al. Jan 2010 A1
20100022825 Yoshie Jan 2010 A1
20100030233 Whitman et al. Feb 2010 A1
20100030248 Palmer et al. Feb 2010 A1
20100036370 Mirel et al. Feb 2010 A1
20100042077 Okada Feb 2010 A1
20100049180 Wells et al. Feb 2010 A1
20100063525 Beaupre et al. Mar 2010 A1
20100063528 Beaupré Mar 2010 A1
20100069940 Miller et al. Mar 2010 A1
20100158307 Kubota et al. Jun 2010 A1
20100187283 Crainich et al. Jul 2010 A1
20100222714 Muir et al. Sep 2010 A1
20100228264 Robinson et al. Sep 2010 A1
20100234906 Koh Sep 2010 A1
20100262134 Jensen et al. Oct 2010 A1
20100274160 Yachi et al. Oct 2010 A1
20100280407 Polster Nov 2010 A1
20100292691 Brogna Nov 2010 A1
20100298743 Nield et al. Nov 2010 A1
20100298851 Nield Nov 2010 A1
20100331742 Masuda Dec 2010 A1
20110004233 Muir et al. Jan 2011 A1
20110009850 Main et al. Jan 2011 A1
20110077648 Lee et al. Mar 2011 A1
20110082486 Messerly et al. Apr 2011 A1
20110087215 Aldridge et al. Apr 2011 A1
20110087217 Yates et al. Apr 2011 A1
20110087218 Boudreaux et al. Apr 2011 A1
20110087256 Wiener et al. Apr 2011 A1
20110112526 Fritz et al. May 2011 A1
20110125151 Strauss et al. May 2011 A1
20110125174 Babaev May 2011 A1
20110144806 Sandhu et al. Jun 2011 A1
20110196399 Robertson et al. Aug 2011 A1
20110224689 Larkin et al. Sep 2011 A1
20110238065 Hunt et al. Sep 2011 A1
20110257650 Deville et al. Oct 2011 A1
20110270126 Gunday et al. Nov 2011 A1
20110290853 Shelton, IV et al. Dec 2011 A1
20110290856 Shelton, IV et al. Dec 2011 A1
20120004655 Kim et al. Jan 2012 A1
20120022525 Dietz et al. Jan 2012 A1
20120022530 Woodruff et al. Jan 2012 A1
20120059289 Nield et al. Mar 2012 A1
20120065628 Naito Mar 2012 A1
20120071863 Lee et al. Mar 2012 A1
20120078139 Aldridge et al. Mar 2012 A1
20120078243 Worrell et al. Mar 2012 A1
20120078244 Worrell et al. Mar 2012 A1
20120078247 Worrell et al. Mar 2012 A1
20120078278 Bales, Jr. et al. Mar 2012 A1
20120080332 Shelton, IV et al. Apr 2012 A1
20120101495 Young et al. Apr 2012 A1
20120116379 Yates et al. May 2012 A1
20120116391 Houser et al. May 2012 A1
20120116394 Timm et al. May 2012 A1
20120116395 Madan et al. May 2012 A1
20120130256 Buysse et al. May 2012 A1
20120130365 McLawhorn May 2012 A1
20120136354 Rupp May 2012 A1
20120138660 Shelton, IV Jun 2012 A1
20120143211 Kishi Jun 2012 A1
20120150170 Buysse et al. Jun 2012 A1
20120165816 Kersten et al. Jun 2012 A1
20120172873 Artale et al. Jul 2012 A1
20120172904 Muir et al. Jul 2012 A1
20120177005 Liang et al. Jul 2012 A1
20120184946 Price et al. Jul 2012 A1
20120199630 Shelton, IV Aug 2012 A1
20120199632 Spivey et al. Aug 2012 A1
20120203143 Sanai et al. Aug 2012 A1
20120203247 Shelton, IV et al. Aug 2012 A1
20120209289 Duque et al. Aug 2012 A1
20120209303 Frankhouser et al. Aug 2012 A1
20120210223 Eppolito Aug 2012 A1
20120215220 Manzo et al. Aug 2012 A1
20120245582 Kimball et al. Sep 2012 A1
20120253370 Ross et al. Oct 2012 A1
20120265196 Turner et al. Oct 2012 A1
20120269676 Houser et al. Oct 2012 A1
20120310262 Messerly et al. Dec 2012 A1
20120330307 Ladtkow et al. Dec 2012 A1
20130012957 Shelton, IV et al. Jan 2013 A1
20130012970 Houser Jan 2013 A1
20130030433 Heard Jan 2013 A1
20130035680 Ben-Haim et al. Feb 2013 A1
20130053840 Krapohl et al. Feb 2013 A1
20130072856 Frankhouser et al. Mar 2013 A1
20130072857 Frankhouser et al. Mar 2013 A1
20130079762 Twomey et al. Mar 2013 A1
20130103023 Monson et al. Apr 2013 A1
20130103024 Monson et al. Apr 2013 A1
20130110145 Weitzman May 2013 A1
20130123776 Monson et al. May 2013 A1
20130123777 Monson et al. May 2013 A1
20130123782 Trees et al. May 2013 A1
20130123822 Wellman et al. May 2013 A1
20130131660 Monson et al. May 2013 A1
20130165929 Muir et al. Jun 2013 A1
20130211397 Parihar et al. Aug 2013 A1
20130217967 Mohr et al. Aug 2013 A1
20130226207 Stulen et al. Aug 2013 A1
20130226208 Wiener et al. Aug 2013 A1
20130245659 Robertson et al. Sep 2013 A1
20130267975 Timm et al. Oct 2013 A1
20130274734 Maass et al. Oct 2013 A1
20130282003 Messerly et al. Oct 2013 A1
20130282038 Dannaher et al. Oct 2013 A1
20130282039 Wiener et al. Oct 2013 A1
20130285758 Aldridge et al. Oct 2013 A1
20130289591 Boudreaux et al. Oct 2013 A1
20130296908 Schulte et al. Nov 2013 A1
20130338661 Behnke, II Dec 2013 A1
20130345733 Robertson et al. Dec 2013 A1
20140005640 Shelton, IV et al. Jan 2014 A1
20140005653 Shelton, IV et al. Jan 2014 A1
20140005654 Batross et al. Jan 2014 A1
20140005656 Mucilli et al. Jan 2014 A1
20140005661 Shelton, IV et al. Jan 2014 A1
20140005662 Shelton, IV et al. Jan 2014 A1
20140005667 Stulen et al. Jan 2014 A1
20140005668 Rhee et al. Jan 2014 A1
20140005676 Shelton, IV et al. Jan 2014 A1
20140005680 Shelton, IV et al. Jan 2014 A1
20140005681 Gee et al. Jan 2014 A1
20140005682 Worrell et al. Jan 2014 A1
20140005701 Olson et al. Jan 2014 A1
20140005702 Timm et al. Jan 2014 A1
20140005703 Stulen et al. Jan 2014 A1
20140005704 Vakharia et al. Jan 2014 A1
20140005705 Weir et al. Jan 2014 A1
20140005708 Shelton, IV et al. Jan 2014 A1
20140005718 Shelton, IV et al. Jan 2014 A1
20140012299 Stoddard et al. Jan 2014 A1
20140058427 Robertson Feb 2014 A1
20140066962 Robertson et al. Mar 2014 A1
20140087569 Lee Mar 2014 A1
20140107538 Wiener et al. Apr 2014 A1
20140114327 Boudreaux et al. Apr 2014 A1
20140135804 Weisenburgh, II et al. May 2014 A1
20140155921 Price et al. Jun 2014 A1
20140180280 Sigmon, Jr. Jun 2014 A1
20140243864 Voegele et al. Aug 2014 A1
20140276738 Price et al. Sep 2014 A1
20140276970 Messerly et al. Sep 2014 A1
20140336686 Houser et al. Nov 2014 A1
20150045819 Houser et al. Feb 2015 A1
20150066067 Stulen Mar 2015 A1
20150073460 Stulen Mar 2015 A1
20150112335 Boudreaux et al. Apr 2015 A1
20150119914 Neurohr et al. Apr 2015 A1
20150119915 Neurohr et al. Apr 2015 A1
20150119916 Dietz et al. Apr 2015 A1
20150123348 Robertson et al. May 2015 A1
20150157355 Price et al. Jun 2015 A1
20150157356 Gee Jun 2015 A1
20150164533 Felder et al. Jun 2015 A1
20150164534 Felder et al. Jun 2015 A1
20150164535 Felder et al. Jun 2015 A1
20150164536 Czarnecki et al. Jun 2015 A1
20150164537 Cagle et al. Jun 2015 A1
20150164538 Aldridge et al. Jun 2015 A1
Foreign Referenced Citations (251)
Number Date Country
2003241752 Sep 2003 AU
1233944 Nov 1999 CN
1253485 May 2000 CN
1634601 Jul 2005 CN
1640365 Jul 2005 CN
1694649 Nov 2005 CN
1922563 Feb 2007 CN
1951333 Apr 2007 CN
101040799 Sep 2007 CN
101467917 Jan 2009 CN
3904558 Aug 1990 DE
9210327 Nov 1992 DE
4323585 Jan 1995 DE
19608716 Apr 1997 DE
20021619 Mar 2001 DE
10042606 Aug 2001 DE
0136855 Sep 1984 EP
0171967 Feb 1986 EP
1839599 Oct 1987 EP
0336742 Apr 1989 EP
0424685 May 1991 EP
0443256 Aug 1991 EP
0456470 Nov 1991 EP
0598976 Jan 1994 EP
0677275 Mar 1995 EP
0482195 Jan 1996 EP
0695535 Feb 1996 EP
0741996 Nov 1996 EP
0612570 Jun 1997 EP
1108394 Jun 2001 EP
0908148 Jan 2002 EP
1229515 Aug 2002 EP
1285634 Feb 2003 EP
0908155 Jun 2003 EP
0705570 Apr 2004 EP
0765637 Jul 2004 EP
0870473 Sep 2005 EP
0624346 Nov 2005 EP
1594209 Nov 2005 EP
1199044 Dec 2005 EP
1609428 Dec 2005 EP
1199043 Mar 2006 EP
1433425 Jun 2006 EP
1256323 Sep 2006 EP
1704824 Sep 2006 EP
1749479 Feb 2007 EP
1815950 Aug 2007 EP
1844720 Oct 2007 EP
1862133 Dec 2007 EP
1875875 Jan 2008 EP
1199045 Jun 2008 EP
1964530 Sep 2008 EP
1972264 Sep 2008 EP
1974771 Oct 2008 EP
1435852 Dec 2008 EP
1498082 Dec 2008 EP
1707131 Dec 2008 EP
1997438 Dec 2008 EP
1477104 Jan 2009 EP
2014218 Jan 2009 EP
2042112 Apr 2009 EP
1832259 Jun 2009 EP
2074959 Jul 2009 EP
2106758 Oct 2009 EP
2111813 Oct 2009 EP
2200145 Jun 2010 EP
1214913 Jul 2010 EP
2238938 Oct 2010 EP
2298154 Mar 2011 EP
1510178 Jun 2011 EP
2305144 Jun 2011 EP
2335630 Jun 2011 EP
1502551 Jul 2011 EP
2361562 Aug 2011 EP
2365608 Sep 2011 EP
2422721 Feb 2012 EP
1927321 Apr 2012 EP
2510891 Oct 2012 EP
2316359 Mar 2013 EP
1586275 May 2013 EP
1616529 Sep 2013 EP
2583633 Oct 2014 EP
2032221 Apr 1980 GB
2317566 Apr 1998 GB
2379878 Nov 2004 GB
2447767 Aug 2011 GB
S 50-100891 Dec 1973 JP
S 59-68513 Oct 1982 JP
62-221343 Sep 1987 JP
S 62-227343 Oct 1987 JP
62-292153 Dec 1987 JP
63-109386 May 1988 JP
63-315049 Dec 1988 JP
H 01-151452 Jun 1989 JP
H 01-198540 Aug 1989 JP
02-71510 May 1990 JP
2-286149 Nov 1990 JP
H 02-292193 Dec 1990 JP
04-25707 Feb 1992 JP
4-30508 Mar 1992 JP
H 04-150847 May 1992 JP
H 04-152942 May 1992 JP
05-095955 Apr 1993 JP
H 06-070938 Mar 1994 JP
6-104503 Apr 1994 JP
6-507081 Aug 1994 JP
H 7-508910 Oct 1995 JP
7-308323 Nov 1995 JP
8-24266 Jan 1996 JP
8-275951 Oct 1996 JP
H 08-299351 Nov 1996 JP
H 08-336545 Dec 1996 JP
H 09-503146 Mar 1997 JP
H 09-135553 May 1997 JP
H 10-005237 Jan 1998 JP
10-295700 Nov 1998 JP
H 11-501543 Feb 1999 JP
H 11-128238 May 1999 JP
H 11-192235 Jul 1999 JP
11-253451 Sep 1999 JP
H 11-318918 Nov 1999 JP
2000-041991 Feb 2000 JP
2000-070279 Mar 2000 JP
2000-210299 Aug 2000 JP
2000-287987 Oct 2000 JP
2001-029353 Feb 2001 JP
2001-502216 Feb 2001 JP
2003612 Jun 2001 JP
2001-309925 Nov 2001 JP
2002-186901 Jul 2002 JP
2002-204808 Jul 2002 JP
2002-263579 Sep 2002 JP
2002-301086 Oct 2002 JP
2002-330977 Nov 2002 JP
2002-542690 Dec 2002 JP
2003-000612 Jan 2003 JP
2003-010201 Jan 2003 JP
2003-510158 Mar 2003 JP
2003-116870 Apr 2003 JP
2003-126110 May 2003 JP
2003-310627 May 2003 JP
2003-530921 Oct 2003 JP
2003-339730 Dec 2003 JP
2004-147701 May 2004 JP
2005027026 Jan 2005 JP
2005-040222 Feb 2005 JP
2005-066316 Mar 2005 JP
2005-074088 Mar 2005 JP
2005-534451 Nov 2005 JP
2006-6410 Jan 2006 JP
2006-512149 Apr 2006 JP
2006-116194 May 2006 JP
2006-158525 Jun 2006 JP
2006-218296 Aug 2006 JP
2006217716 Aug 2006 JP
2006-288431 Oct 2006 JP
2007-050181 Mar 2007 JP
2003-126104 May 2007 JP
2007-229454 Sep 2007 JP
2007-527747 Oct 2007 JP
2008-508065 Mar 2008 JP
2008-119250 May 2008 JP
2008-521503 Jun 2008 JP
2008-212679 Sep 2008 JP
2008-284374 Nov 2008 JP
2009-511206 Mar 2009 JP
2009-517181 Apr 2009 JP
4262923 May 2009 JP
2009-523567 Jun 2009 JP
2009-236177 Oct 2009 JP
2010-000336 Jan 2010 JP
2010-514923 May 2010 JP
2010-540186 Dec 2010 JP
2012-235658 Nov 2012 JP
5208761 Jun 2013 JP
2154437 Aug 2000 RU
WO 9222259 Dec 1992 WO
WO 9308757 May 1993 WO
WO 9314708 Aug 1993 WO
WO 9316646 Sep 1993 WO
WO 9320877 Oct 1993 WO
WO 9421183 Sep 1994 WO
WO 9424949 Nov 1994 WO
WO 9509572 Apr 1995 WO
WO 9630885 Oct 1996 WO
WO 9639086 Dec 1996 WO
WO 9816156 Apr 1998 WO
WO 98026739 Jun 1998 WO
WO 9835621 Aug 1998 WO
WO 9837815 Sep 1998 WO
WO 9847436 Oct 1998 WO
WO 9920213 Apr 1999 WO
WO 9952489 Oct 1999 WO
WO 0064358 Nov 2000 WO
WO 0074585 Dec 2000 WO
WO 0154590 Aug 2001 WO
WO 0167970 Sep 2001 WO
WO 0195810 Dec 2001 WO
WO 0224080 Mar 2002 WO
WO 0238057 May 2002 WO
WO 02062241 Aug 2002 WO
WO 03082133 Oct 2003 WO
WO 2004012615 Feb 2004 WO
WO 2004026104 Apr 2004 WO
WO 2004032754 Apr 2004 WO
WO 2004032762 Apr 2004 WO
WO 2004032763 Apr 2004 WO
WO 2004037095 May 2004 WO
WO 2004098426 Nov 2004 WO
WO 2004112618 Dec 2004 WO
WO 2005117735 Dec 2005 WO
WO 2005122917 Dec 2005 WO
WO 2006012797 Feb 2006 WO
WO 2006042210 Apr 2006 WO
WO 2006058223 Jun 2006 WO
WO 2006063199 Jun 2006 WO
WO 2006083988 Aug 2006 WO
WO 2006119139 Nov 2006 WO
WO 2006119376 Nov 2006 WO
WO 2006129465 Dec 2006 WO
WO 2007008703 Jan 2007 WO
WO 2007008710 Jan 2007 WO
WO 2007040818 Apr 2007 WO
WO 2007047380 Apr 2007 WO
WO 2007047531 Apr 2007 WO
WO 2007056590 May 2007 WO
WO 2007087272 Aug 2007 WO
WO 2007143665 Dec 2007 WO
WO 2008016886 Feb 2008 WO
WO 2008042021 Apr 2008 WO
WO 2008049084 Apr 2008 WO
WO 2008051764 May 2008 WO
WO 2008089174 Jul 2008 WO
WO 2008118709 Oct 2008 WO
WO 2008130793 Oct 2008 WO
WO 2009010565 Jan 2009 WO
WO 2009018406 Feb 2009 WO
WO 2009027065 Mar 2009 WO
WO 2009046234 Apr 2009 WO
WO 2009120992 Oct 2009 WO
WO 2010068783 Jun 2010 WO
WO 2011008672 Jan 2011 WO
WO 2011052939 May 2011 WO
WO 2011100321 Aug 2011 WO
WO 2011144911 Nov 2011 WO
WO 2012061722 May 2012 WO
WO 2012128362 Sep 2012 WO
WO 2012135705 Oct 2012 WO
WO 2012135721 Oct 2012 WO
WO 2013018934 Feb 2013 WO
WO 2013062978 May 2013 WO
Non-Patent Literature Citations (29)
Entry
International Search Report for PCT/GB2011/000778, dated Oct. 19, 2011 (8 pages).
Technology Overview, printed from www.harmonicscalpel.com, Internet site, website accessed on Jun. 13, 2007, (3 pages).
Sherrit et al., “Novel Horn Designs for Ultrasonic/Sonic Cleaning Welding, Soldering, Cutting and Drilling,” Proc. SPIE Smart Structures Conference, vol. 4701, Paper No. 34, San Diego, CA, pp. 353-360, Mar. 2002.
AST Products, Inc., “Principles of Video Contact Angle Analysis,” 20 pages, (2006).
Lim et al., “A Review of Mechanism Used in Laparoscopic Surgical Instruments,” Mechanism and Machine Theory, vol. 38, pp. 1133-1147, (2003).
Gooch et al., “Recommended Infection-Control Practices for Dentistry, 1993,” Published: May 28, 1993; [retrieved on Aug. 23, 2008]. Retrieved from the internet: URL: http//wonder.cdc.gov/wonder/prevguid/p0000191/p0000191.asp (15 pages).
Huston et al., “Magnetic and Magnetostrictive Properties of Cube Textured Nickel for Magnetostrictive Transducer Applications,” IEEE Transactions on Magnetics, vol. 9(4), pp. 636-640 (Dec. 1973).
Incropera et al., “Fundamentals of Heat and Mass Transfer”, Wiley, New York (1990). (Book—not attached).
F. A. Duck, “Optical Properties of Tissue Including Ultraviolet and Infrared Radiation,” pp. 43-71 in Physical Properties of Tissue (1990).
Orr et al., “Overview of Bioheat Transfer,” pp. 367-384 in Optical-Thermal Response of Laser-Irradiated Tissue, A. J. Welch and M. J. C. van Gemert, eds., Plenum, New York (1995).
Campbell et al, “Thermal Imaging in Surgery,” p. 19-3, in Medical Infrared Imaging, N. A. Diakides and J. D. Bronzino, Eds. (2008).
Sullivan, “Cost-Constrained Selection of Strand Diameter and Number in a Litz-Wire Transformer Winding,” IEEE Transactions on Power Electronics, vol. 16, No. 2, Mar. 2001, pp. 281-288.
Sullivan, “Optimal Choice for Number of Strands in a Litz-Wire Transformer Winding,” IEEE Transactions on Power Electronics, vol. 14, No. 2, Mar. 1999, pp. 283-291.
Graff, K.F., “Elastic Wave Propagation in a Curved Sonic Transmission Line,” IEEE Transactions on Sonics and Ultrasonics, SU-17(1), 1-6 (1970).
Makarov, S. N., Ochmann, M., Desinger, K., “The longitudinal vibration response of a curved fiber used for laser ultrasound surgical therapy,” Journal of the Acoustical Society of America 102, 1191-1199 (1997).
Morley, L. S. D., “Elastic Waves in a Naturally Curved Rod,” Quarterly Journal of Mechanics and Applied Mathematics, 14: 155-172 (1961).
Walsh, S. J., White, R. G., “Vibrational Power Transmission in Curved Beams,” Journal of Sound and Vibration, 233(3), 455-488 (2000).
http://www.apicalinstr.com/generators.htm.
http://www.dotmed.com/listing/electrosurical-unit/ethicon/ultracision-g110-/1466724.
http:/www.ethicon.com/gb-en/healthcare-professionals/products/energy-devices/capital//ge . . . .
http://www.4-traders.com/JOHNSON-JOHNSON-4832/news/Johnson-Johnson-Ethicon-E . . .
http://www.medicalexpo.com/medical-manufacturer/electrosurgical-generator-6951.html.
http://www.meqadyne.com/es—generator.php.
http://www.valleylab.com/product/es/generators/index.html.
Covidien 501(k) Summary Sonicision, dated Feb. 24, 2011 (7 pages).
Gerhard, Glen C., “Surgical Electrotechnology: Quo Vadis?,” Biomedical Engineering, IEEE Transactions on , vol. BME-31, No. 12, pp. 787, 792, Dec. 1984.
Fowler, K.R., “A programmable, arbitrary waveform electrosurgical device,” Engineering in Medicine and Biology Society, 1988. Proceedings of the Annual International Conference of the IEEE, vol., No., pp. 1324, 1325 vol. 3, Nov. 4-7, 1988.
LaCourse, J.R.; Vogt, M.C.; Miller, W.T., III; Selikowitz, S.M., “Spectral analysis interpretation of electro-surgical generator nerve and muscle stimulation,” Biomedical Engineering, IEEE Transactions on , vol. 35, No. 7, pp. 505, 509, Jul. 1988.
U.S. Appl. No. 13/751,680, filed Jan. 28, 2013.
Related Publications (1)
Number Date Country
20130345689 A1 Dec 2013 US